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Abstract 
The loss of dopaminergic neurons is a hallmark of Parkinson’s disease, the aetiology of which is 
thought to encompass increased levels of oxidative stress and protein misfolding. We used C. 
elegans to screen for genes that protect dopaminergic neurons from oxidative stress inflicted 
by 6-hydroxydopamine (6-OHDA) uptake and isolated the neuroligin-like gene glit-1 and the 
transthyretin-related gene ttr-33. Neuroligins are transmembrane proteins involved in the 
development and function of synapses. We provide evidence that glit-1 and the previously 
identified tetraspanin tsp-17 are associated with the regulation of dopamine turnover, 
impacting on 6-OHDA uptake into the neurons: glit-1 and tsp-17 mutant sensitivities to 6-
OHDA are not additive and both mutants exhibit signs of increased dopamine signalling. A 
Pglit-1::GFP transcriptional reporter is expressed in the pharynx, intestine and possibly 
dopaminergic neurons. The second isolated mutant ttr-33 in contrast does not display 
dopamine-related behavioural defects. TTR-33 is likely secreted from the posterior arcade cells 
in the head and might play a role in cell engulfment, similar to another member of the C. 
elegans transthyretin-related protein family. C. elegans dopaminergic neurons seem to be 
phagocytosed after 6-OHDA intoxication as mutations in the engulfment pathway largely 
suppress neuronal loss. Before being engulfed, dopaminergic neurons likely undergo a 
necrosis-like cell death − since mutations in apoptosis pathway genes do not prevent, but 
rather increase neurodegeneration. In addition, the mutated TTR-33 protein might be more 
prone to aggregation, similar to its human orthologue transthyretin which is associated with 
amyloid diseases. Indeed, inhibition of the C. elegans unfolded protein response partly 
alleviates dopaminergic neurodegeneration in the ttr-33 mutant. On the organismal level, glit-
1, tsp-17 and ttr-33 mutations cause oxidative stress sensitivity but resistance to protein 
folding stress. In summary, we think that tsp-17, glit-1 and ttr-33 play a role in the organismal 
defence against environmental stress. 
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1 GENERAL INTRODUCTION 
1.1 Dopamine function and signalling 
Dopamine is a neurotransmitter that functions in distinct parts of the brain to control diverse 
behaviours such as movement, attention, cognition and motivation (Schultz, 2007). 
Dopaminergic signalling parallels classical neurotransmission (Figure 1): After production in 
dopaminergic neurons, dopamine is stored in presynaptic vesicles and released into the 
synaptic cleft upon intracellular calcium stimulation (Standaert and Galanter, 2008). Upon 
synaptic release, the neurotransmitter binds to postsynaptic excitatory or inhibitory receptors 
which stimulate or prevent influx of extracellular Ca2+ into the postsynaptic neuron, 
respectively (Lodish et al., 2000). Dopamine is taken back up into the presynaptic neuron via 
the dopamine transporter for recycling or degradation (Standaert and Galanter, 2008). 
Erroneous dopamine signalling is associated with distinct disorders such as Parkinson’s disease 
(PD), attention deficit hyperactivity disorder (ADHD) and Schizophrenia (Schultz, 2016). 
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Figure 1: Dopaminergic metabolism, recycling and degradation – from (Standaert 
and Galanter, 2008). 
Dopamine (DA) synthesis starts with the amino acid tyrosine and produces the 
intermediate product L-3,4-dihydroxyphenylalanine (L-DOPA). Dopamine is packed 
into secretory vesicles by the vesicular monoamine transporter (VMAT), an 
antiporter which requires the action of a proton ATPase to establish a gradient of 
protons in the vesicle. When an action potential arrives, the influx of Ca2+ triggers 
dopamine vesicle release into the synaptic cleft where dopamine can bind to 
postsynaptic receptors or presynaptic autoreceptors. Most of the dopamine is 
then taken up into the dopaminergic neuron again via the dopamine transporter 
which co-transports Na+. Back inside the neuron, dopamine can be degraded to 
3,4 – dihydroxyphenylacetic acid (DOPAC) by monoamine oxidases (MAO). 
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1.2 Pathophysiology of Parkinson’s disease 
1.2.1 Parkinson’s disease symptoms and occurrence 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and has a 
prevalence of 1% in the population over 60 (Lau and Breteler, 2006). The characteristic motor 
symptoms of PD – resting tremor, poor balance, rigidity and slow involuntary movement – are 
caused by the progressive loss of dopaminergic neurons in the substantia nigra (Duda et al., 
2016). In addition, neurodegeneration also occurs in other parts of the brain, relating to some 
of the non-motor symptoms of the disorder (Chaudhuri et al., 2011). There is no cure for PD to 
date and even the ‘gold standard’ treatment, the supply of the dopamine precursor L-DOPA (L-
3,4-dihydroxyphenylalanine), leads to severe side effects (Sarkar et al., 2016). To improve 
therapy or even prevent disease onset, the molecular mechanisms of PD need to be better 
understood. 
The aetiology of PD is multifactorial with the majority of disease cases being evoked by the 
interplay of one or multiple genetic defects and environmental factors (Klein and 
Westenberger, 2012). Less than 10% of PD patients report a positive family history while the 
majority of instances are sporadic (Thomas and Beal, 2007). Furthermore, single gene 
mutations only account for about 30% of familial and 3-5% of sporadic PD incidences (Klein 
and Westenberger, 2012). Among these monogenetic PD loci there are recessive ones such as 
PINK1, parkin and DJ-1 – for which both gene copies need to be mutated to evoke a phenotype 
and which are therefore associated with gene loss-of-function. In addition, there are dominant 
PD loci such as α-synuclein and LRRK2 – for which a single mutant copy is sufficient to induce a 
phenotype (Klein and Westenberger, 2012). A dominant phenotype can be provoked by a) 
haploinsufficiency, i.e. a single copy of the gene is not enough to provide function, b) a 
dominant negative effect, i.e. the mutant allele interferes with the normal allele, or c) a gain-
of-function mutation that makes the gene product adopt an abnormal function (Klein and 
Westenberger, 2012). In addition to genetic causes, rare cases of sporadic PD incidences can 
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be purely connected to environmental exposure, such as the accidental ingestion of 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Duda et al., 2016). Since there is a substantial 
overlap of clinical features between genetic and sporadic PD, common pathophysiological 
mechanisms might underlie neurodegeneration in both forms of the disease (Haddad and 
Nakamura, 2015). Shared factors such as mitochondrial and lysosomal dysfunction, metabolic 
stress and impaired Ca2+ homeostasis are thought to reinforce each other and trigger PD (Duda 
et al., 2016).  
PD is discussed to reflect a form of accelerated aging (Duda et al., 2016). Hallmarks of aging 
such as mitochondrial dysfunction and loss of proteostasis (López-Otín et al., 2013) also 
represent risk factors for PD (Duda et al., 2016). Furthermore, aging itself increases the 
chances to develop PD, and neurons vulnerable to degeneration with age are also vulnerable 
to degeneration in PD (Duda et al., 2016).  
1.2.2 Oxidative stress in Parkinson’s disease 
Dopaminergic neurons, especially those in the substantia nigra, seem to be particularly 
sensitive to PD risk factors and one reason for this could be dopamine metabolism itself 
(Caudle et al., 2008). Cytosolic dopamine can auto-oxidise to highly neurotoxic compounds and 
reactive oxygen species (ROS) such as OH·,O·-2 and H2O2 (Caudle et al., 2008). Synaptic vesicle 
storage of dopamine can prevent cellular damage, but this safe-keeping seems diminished in 
neurons in the substantia nigra and is further disrupted by PD risk factors (Caudle et al., 2008). 
In addition, the enzymatic degradation of dopamine results in the production of H2O2 and this 
additional source of ROS might increase the vulnerability of dopaminergic neurons even 
further (Caudle et al., 2008).  
An imbalance between the production of ROS and the endogenous defence against these 
molecules leads to ‘oxidative stress’ (Finkel and Holbrook, 2000), a major risk factor for PD 
(Duda et al., 2016). ROS can damage proteins, lipids and mitochondria, leading to a self-
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accelerating loop of cellular damage and ultimately cell death (Duda et al., 2016). Oxidative 
stress defence systems have evolved to prevent damage to the cell and the sulphur-containing 
amino acids cysteine and methionine form part of important antioxidants (Kim et al., 2014; Lu 
and Holmgren, 2014). Consistent with the idea that increased levels of oxidative stress are a 
major component in the pathogenesis of PD, the substantia nigra of PD patients was reported 
to contain decreased levels of the cysteine-containing antioxidant glutathione (Sian et al., 
1994). In addition, mutation of DJ-1, a protein which acts as a redox sensor or antioxidant 
protein, is associated with the development of PD (Abou-Sleiman et al., 2006). Finally, 
oxidative stress induced by the herbicide paraquat (Tanner et al., 2011; Wang et al., 2011) and 
exposure to pesticides is associated with a higher incidence of PD (Priyadarshi et al., 2001). In 
summary, there is evidence that increased oxidative damage raises the risk to develop PD 
(Haddad and Nakamura, 2015). 
1.2.3 Mitochondrial dysfunction in Parkinson’s disease 
The mitochondrial electron transport chain is one of the main energy sources and is assumed 
to generate most of the reactive oxygen species (ROS) in the cell (Hekimi et al., 2011; Sena and 
Chandel, 2012). Mitochondrial stress – induced by excessive demand for mitochondrial 
functions or by mitochondrial damage – is discussed to contribute to PD (Haddad and 
Nakamura, 2015). Dysfunction of mitochondria leads to decreased cellular energy production 
(Haddad and Nakamura, 2015). However, the substantia nigra population of dopaminergic 
neurons might have unusually high energy requirements − since they target more neurons 
than neighbouring dopaminergic neurons that are unaffected by PD (Haddad and Nakamura, 
2015). In addition, dopaminergic neurons in the substantia nigra use an unusual and energy-
intensive Ca2+ gradient to exert their pacemaking activity (Haddad and Nakamura, 2015) – a 
regular and intrinsically generated firing pattern with low frequency (Duda et al., 2016). 
Remarkably, the redox sensor DJ-1, which is linked to the development of PD, was reported to 
attenuate oxidative stress evoked by this pacemaking function (Guzman et al., 2010). In 
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addition to reducing cellular energy production, interference with the mitochondrial electron 
transport chain also leads to the leakage of electrons and subsequently to increased 
generation of ROS (Haddad and Nakamura, 2015). Several lines of evidence directly link 
inhibition of the electron transport chain to the development of PD (Haddad and Nakamura, 
2015). A metabolite of the drug MPTP inhibits complex I of the electron transport chain 
(Nicklas et al., 1985) and induces selective dopaminergic neurodegeneration in the substantia 
nigra as well as PD symptoms (Duda et al., 2016). Another complex I inhibitor, rotenone, leads 
to PD-like symptoms (including Lewy body-like aggregates) in rats (Betarbet et al., 2000). 
Finally, a complex I deficiency was identified in the substantia nigra of PD patients (Schapira et 
al., 1989).  
Apart from their function in energy production, mitochondria are involved in the regulation of 
calcium signalling and cell death (Kroemer et al., 2007). Intact mitochondria maintain their 
membrane potential and sustain cellular calcium homeostasis (Haddad and Nakamura, 2015). 
In apoptotic and necrotic cells, however, the mitochondrial membrane potential is lost, the 
mitochondrial permeability transition pores open and apoptogenic proteins and Ca2+ are 
released (Brenner and Moulin, 2012).  
Damaged mitochondria display a loss of membrane potential and can be disposed of by a 
specific form of autophagy termed mitophagy (Kazlauskaite and Muqit, 2015; Pickrell and 
Youle, 2015; Ploumi et al., 2016). The autosomal recessive PD loci PINK1 and parkin (Kitada et 
al., 1998; Valente et al., 2004) mediate mitophagy and a malfunction of this process seems to 
contribute to PD (Kazlauskaite and Muqit, 2015; Pickrell and Youle, 2015; Ploumi et al., 2016). 
Mitochondrial membrane depolarisation activates the kinase PINK1, which then 
phosphorylates ubiquitin (Kane et al., 2014; Kazlauskaite et al., 2014a; Koyano et al., 2014), as 
well as parkin within its autoinhibitory ubiquitin-like domain (Kondapalli et al., 2012; Shiba-
Fukushima et al., 2012). Both phosphorylation events stimulate parkin E3 ubiquitin ligase 
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activity (Kazlauskaite et al., 2014a, 2014b, 2015; Koyano et al., 2014; Ordureau et al., 2014), 
leading to the ubiquitination of mitochondrial substrates to trigger mitophagy (Kazlauskaite 
and Muqit, 2015). 
Drosophila was the first model organism in which PINK1 or parkin mutants were shown to 
possess severe mitochondrial defects (Clark et al., 2006; Park et al., 2006). Inhibition of the 
parkin-antagonising deubiquitinase USP30 reduces mitochondrial and behavioural defects of 
PINK1 or parkin-deficient flies (Bingol et al., 2014). Furthermore, USP30 knockdown specifically 
in dopaminergic neurons protects flies against toxicity of the mitochondrial toxin paraquat 
(Bingol et al., 2014). A connection between mitochondrial damage and the generation of 
oxidative stress is supported by data showing that neurodegeneration in parkin null flies is 
enhanced in glutathione S-transferase null mutants (Whitworth et al., 2005). In addition, 
parkin null flies exhibit increased oxidative damage and a higher innate immune response 
signalling (Greene et al., 2005). Remarkably, Drosophila with a mutation in the PD risk gene 
and redox sensor DJ-1 show similar defects as PINK1 and parkin mutants and upregulation of 
DJ-1 can ameliorate PINK1 mutant phenotypes (Hao et al., 2010). 
More recently, also C. elegans PINK1/pink-1 and parkin/pdr-1 mutants have been shown to 
exhibit defects in mitophagy and a compromised stress resistance (Palikaras et al., 2015). 
Inhibition of C. elegans mitophagy leads to increased production of mitochondrial ROS and 
higher levels of cytoplasmic calcium (Palikaras et al., 2015). These results from the C. elegans 
mitophagy model further support the link between mitochondrial damage and oxidative stress 
production.  
In mice, parkin deficiency results in reduced mitochondrial respiratory capacity and increased 
oxidative damage, but does not lead to neurodegeneration on its own (Abou-Sleiman et al., 
2006). Therefore, even in the background of compromised mitochondrial function, additional 
insults might be needed to trigger PD-like symptoms (Abou-Sleiman et al., 2006).  
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1.2.4 Calcium homeostasis in Parkinson’s disease 
Environmental toxins that cause mitochondrial dysfunction can worsen defects in 
mitochondrial Ca2+ buffering capacity (Wojda et al., 2008). Remarkably, age-related Ca2+ 
dyshomeostasis has been proposed to be the dominant condition causing neurodegeneration 
in sporadic PD (Wojda et al., 2008). In support of a damaging effect of cytosolic Ca2+, L-type 
calcium channel blockers that inhibit cellular Ca2+ entry reduce the risk of developing PD (Duda 
et al., 2016). In addition, neurons that are vulnerable in PD express lower levels of the cytosolic 
Ca2+-binding protein calbindin (Duda et al., 2016). Thus, in the substantia nigra Ca2+ needs to 
be mainly buffered via uptake into mitochondria, lysosomes or the endoplasmic reticulum 
(ER), and this likely imposes additional stress on these organelles (Duda et al., 2016). 
1.2.5 Protein folding and degradation in Parkinson’s disease 
A common hallmark for sporadic and familial cases of PD is the observation of Lewy bodies – 
abnormal intracellular protein aggregates in surviving dopaminergic neurons (Spillantini et al., 
1997). The main component of Lewy bodies is α-synuclein (Spillantini et al., 1997), a protein 
which is encoded by an autosomal dominant PD locus (Polymeropoulos et al., 1997). α-
synuclein has been shown to prevent neurodegeneration (Chandra et al., 2005) and mutations 
are thought to increase the propensity of the protein to polymerise and form fibrils (Bertoncini 
et al., 2005). Hence, PD might be triggered by reduced α-synuclein protection or by a gain-of-
function mechanism based on α-synuclein aggregation. If the second scenario is the case, Lewy 
bodies may represent an attempt to encapsulate these toxic α-synuclein derivates in the cell 
(Chen and Feany, 2005). Furthermore, dopamine was shown to modulate α-synuclein 
aggregation, providing an explanation for the selective dopaminergic neurodegeneration in an 
α-synuclein mutant background (Conway et al., 2001).  
Generally, the imbalance of protein synthesis and protein degradation may cause 
accumulation of defective proteins, leading to cell damage and ultimately cell death (Hipp et 
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al., 2014). If there is an accumulation of unfolded or misfolded proteins in the ER – the major 
site for protein synthesis and maturation – the unfolded protein response (UPR) is triggered to 
prevent detrimental cellular effects (Urra et al., 2013). The UPR first increases protein folding 
and clearance capacity to reduce the amount of misfolded proteins and to restart translation 
(Urra et al., 2013). However, under chronic ‘ER stress’, the UPR triggers apoptosis to eliminate 
irreversibly damaged cells, possibly by controlling cellular ROS production and ER calcium 
release (Urra et al., 2013). The E3 ubiquitin ligase parkin tags proteins for proteasomal 
degradation, therefore a mutation in the autosomal recessive PD locus is expected to 
exacerbate ER stress (Varma and Sen, 2015). In addition to the cellular protection conferred by 
the UPR, the autophagy and the proteasome pathway survey for and eliminate aggregated or 
dysfunctional proteins (Charmpilas et al., 2015). Several PD risk genes are associated with the 
autophagy-lysosome pathway, including the lysosomal glucocerebrosidase (GBA), and likely 
lead to defects in intracellular protein degradation (Duda et al., 2016). In addition, several pro-
apoptotic proteins are normally degraded by the proteasome; thus, if proteasomal function is 
inhibited, cell death can be triggered (Abou-Sleiman et al., 2006).  
1.2.6 Interplay of Parkinson’s disease mechanisms 
Besides α-synuclein, LRRK2 (Leucine-rich repeat kinase 2) is the second confirmed autosomal 
dominant PD locus for which a gain-of-function mechanism would be expected. Indeed, one of 
the LRRK2 disease mutations was shown to stimulate kinase activity in vitro (Jaleel et al., 
2007), as well as in heterozygous and homozygous mutant mice (Yue et al., 2015). 
Furthermore, the Lrrk2 mutant mice exhibited mitochondrial abnormalities and a reduction in 
induced dopamine release (Yue et al., 2015). The physiological and pathological roles of LRRK2 
are still unclear, but accumulating evidence suggests that LRRK2 mutations are linked to 
mitochondrial dysfunction and abnormal autophagy (Rosenbusch and Kortholt, 2016). In 
addition, it was reported that LRRK2 is highly expressed in immune cells and that stimulation 
18 
 
of the Toll-Like Receptor innate immune pathway leads to LRRK2 phosphorylation (Dzamko et 
al., 2012). 
The mechanisms that are assumed to underlie PD − such as increased oxidative stress, protein 
misfolding and aggregation and Ca2+ dyshomeostasis − exacerbate each other during disease 
development (Duda et al., 2016). Primary and secondary roles can be difficult to disentangle: 
proteasomal stress in neurons for example can result in increased sensitivity to complex I 
inhibition, and complex I defects can result in decreased proteasome activity (Höglinger et al., 
2003; Sullivan et al., 2004). There is also a connection between oxidative stress and ER stress, 
and both can lead to increased Ca2+ leakage from the ER (Malhotra and Kaufman, 2007). 
Furthermore, autophagy seems required to overcome oxidative stress conditions (Filomeni et 
al., 2015) − whereas dysfunctional autophagy can lead to the accumulation of damaged 
mitochondria (Lee et al., 2012).  
In summary, the loss of dopaminergic neurons is very likely due to a combination of exogenous 
stressors and genetic predisposition that renders the cells less capable of dealing with the 
stress (Abou-Sleiman et al., 2006).  
1.3 C. elegans 6-OHDA-induced dopaminergic neurodegeneration as a Parkinson’s 
disease model 
Experimental approaches to investigate dopaminergic neurons in humans are limited to non-
invasive methods and post-mortem samples. For molecular investigations in vivo, animal 
models are needed. There are genetic and neurotoxic models of PD; however, they all have 
their own advantages and no animal model fully represents the pathophysiology and the 
progressive nature of the disease (Le et al., 2014).  
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1.3.1 The 6-OHDA toxin model of Parkinson’s disease 
A classic toxin to model PD is 6-hydroxydopamine (6-OHDA), a hydroxylated analogue of 
dopamine which acts by inducing intracellular oxidative stress (Bové and Perier, 2012). 6-
OHDA was found in human brain samples (Curtius et al., 1974) and in higher concentrations in 
the urine of PD patients (Andrew et al., 1993). 6-OHDA is structurally highly similar to 
dopamine and norepinephrine and exhibits high affinity to the receptors of these 
neurotransmitters (Kostrzewa and Jacobowitz, 1974). In line with this, 6-OHDA was shown to 
accumulate and act selectively in dopaminergic and noradrenergic neurons (Kostrzewa and 
Jacobowitz, 1974). Inside the neurons, 6-OHDA leads to reactive oxygen species (ROS) 
formation and inhibits complex I of the mitochondrial electron transport chain (Kostrzewa and 
Jacobowitz, 1974; Schober, 2004). ROS production and the depletion of neuronal energy stores 
is assumed to underlie 6-OHDA-induced neurodegeneration (Glinka et al., 1997). In C. elegans, 
noradrenaline and adrenaline cannot be detected (Horvitz et al., 1982; Sanyal et al., 2004), so 
it is expected that 6-OHDA specifically targets dopaminergic neurons.  
1.3.2 C. elegans as a model organism for dopaminergic cell death 
The nematode Caenorhabditis elegans was introduced as an experimental model organism by 
Sydney Brenner (Brenner, 1974). C. elegans follows a well-defined and largely invariant life 
cycle which makes it possible to trace the fate of every cell (Sulston and Horvitz, 1977; Sulston 
et al., 1983). Starting from the embryo, there are four larval stages (L1-L4) before the worm 
reaches adulthood (Sulston and Horvitz, 1977; Sulston et al., 1983). The transparency and 
genetic malleability of C. elegans, as well as sophisticated molecular tools made it possible to 
uncover basic mechanism of cell death and neurobiology (Kaletta and Hengartner, 2006). 
Despite the worms’ small nervous system, most of the known dopamine signalling 
components are conserved between C. elegans and mammals (Nass et al., 2001). 
Dopaminergic neurons in C. elegans are not essential for viability or overt movement but are, 
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similar to their human counterparts, required to mediate subtle behaviours that are often 
connected to motion (Nass et al., 2001). C. elegans hermaphrodites possess eight ciliated and 
mechanosensory dopaminergic neurons – four CEP (cephalic sensilla) and two ADE (anterior 
deirids) neurons in the head and two PDE (posterior deirids) neurons in the midbody (Sulston 
et al., 1975) (Figure 3A). Specific fluorescent in vivo labelling of dopaminergic neurons is 
achieved by using the promoter of the dopamine transporter to drive GFP expression (BY200 
strain, Nass et al., 2002) (Figure 2A). 
1.3.3 C. elegans 6-OHDA model 
After exposure to 6-OHDA, C. elegans dopaminergic neurons – mainly the CEPs and ADEs in the 
head – display blebbed processes, dark and rounded cell bodies and are eventually completely 
lost (Nass et al., 2002). Chromatin condensation, a feature reminiscent of apoptotic cell death, 
is evident; however, interference with the classical apoptosis pathway does not prevent 
dopaminergic neurodegeneration (Nass et al., 2002). Intriguingly, typical signs of necrotic cell 
death such as membranous whorls, swollen organelles or cell bodies are absent as well (Nass 
et al., 2002). However, autophagy seems to play a role in 6-OHDA-induced neurodegeneration 
since mutations of autophagy genes reduce neuronal loss (Tóth et al., 2007). In line with 
studies in other model organisms, 6-OHDA seems to be taken up by the dopamine transporter 
and compete with dopamine for entry, as overexpression of the dopamine synthesis enzyme 
CAT-2 protects against 6-OHDA toxicity in C. elegans (Masoudi et al., 2014). However, in the 
absence of 6-OHDA exposure – and in line with a detrimental effect of high intracellular 
concentration of dopamine – overexpression of the key dopamine synthesis enzyme CAT-2 was 
shown to induce age-dependent dopaminergic cell death (Cao et al., 2005; Masoudi et al., 
2014).  
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Using the C. elegans 6-OHDA model of dopaminergic cell death, previous work from our lab 
showed that the tetraspanin tsp-17 acts in dopaminergic neurons and alleviates 6-OHDA-
induced neurodegeneration (Masoudi et al., 2014).  
 
 
Aim 
To find and characterise genes that prevent the loss of dopaminergic neurons after exposure 
to 6-hyroxydopamine (6-OHDA), I will extend the genetic screen that led to the isolation of tsp-
17. Firstly, I aim to isolate and map novel gene mutations that render C. elegans susceptible to 
6-OHDA-induced neurodegeneration. Secondly, I want to determine the mechanisms by which 
the identified genes normally prevent dopaminergic neurodegeneration in C. elegans.  
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2 RESULTS GLIT-1, TTR-33 AND TSP-17 MUTANTS 
2.1 Premature 6-OHDA-induced neurodegeneration in glit-1 and ttr-33 mutants 
C. elegans worms with mutations in genes necessary for neuronal survival are expected to 
exhibit increased neuronal loss when exposed to a low dose of a neurodegenerative drug. To 
find genes that prevent dopaminergic neuron death, worms with GFP-labelled dopaminergic 
neurons (Figure 2A, B) were mutagenised with ethyl methanesulfonate (EMS). This population 
of worms was then screened for mutants that lost their fluorescent dopaminergic head 
neurons upon intoxication with 6-Hydroxydopamine (6-OHDA) at a concentration that did not 
lead to neuronal loss in wild-type animals (Figure 2B). 6-OHDA is a neurodegenerative drug 
that is taken up specifically into dopaminergic neurons and that is assumed to cause 
intracellular oxidative stress (Kostrzewa and Jacobowitz, 1974). With this screen we expected 
to reveal mutations in genes that have a role in drug uptake, oxidative stress response or cell 
death. 
The mutagen EMS produces random mutations in the genome; hence a mapping procedure is 
needed to identify the mutations that lead to premature neurodegeneration. For mapping, we 
selected mutant lines that developed dopaminergic neurons normally but exhibited strong 
degeneration after treatment with 6-OHDA. These strains were backcrossed and retested to 
eliminate mutations that are not linked to 6-OHDA sensitivity. The mutations in the two lines 
with the strongest 6-OHDA sensitivity, gt1981 and gt1983, behaved in a recessive fashion and 
therefore result likely in a loss-of-function of the affected genes: In contrast to gt1981/gt1981 
and gt1983/gt1983 homozygous mutants (Figure 2B), gt1981/wild-type and gt1983/wild-type 
heterozygous mutants did not exhibit neurodegeneration upon treatment with 6-OHDA (data 
not shown). In addition, we tested complementation of the mutations. If gt1981 and gt1983 
would affect the same gene product, worms carrying one mutation each are expected to be 
still sensitive to 6-OHDA. However, gt1981/gt1983 transheterozygotes behaved like wild-type 
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animals in the 6-OHDA assay (data not shown). Finally, to identify the genes that are mutated 
in gt1981 and gt1983, we conducted whole-genome sequencing and single nucleotide 
polymorphism mapping (Doitsidou et al., 2010; Minevich et al., 2012). Using this strategy, 
mutations in the genes glit-1 and ttr-33 were determined for the lines carrying gt1981 and 
gt1983, respectively. A fosmid carrying the glit-1 wild-type gene rescued the hypersensitivity 
of glit-1(gt1981) (Moerman fosmid library clone WRM0632dG03, data not shown). In addition, 
strains with a glit-1 splice-site mutation (glit-1(gk384527) or glit-1(splice)), a glit-1 promoter 
deletion (glit-1(ok237) or glit-1(Δ)) (Figure 2D) and a ttr-33 point mutation (ttr-33(gk567379) 
or ttr-33(L72F)) (Figure 2E) were acquired from public strain collections and were confirmed to 
be hypersensitive to 6-OHDA (Figure 2B). The shared phenotype between mutants carrying a 
glit-1 promoter deletion and mutants with a glit-1(gt1981) point mutation further supported 
the idea that the point mutation leads to a loss-of-function of glit-1. We crossed the new 
alleles to the isolated mutants to confirm that they affect the same gene. Indeed, the 
mutations did not complement each other since glit-1(gt1981)/glit-1(splice), glit-
1(gt1981)/glit-1(Δ) and ttr-33(gt1983)/ttr-33(L72F) transheterozygous mutants were still 
hypersensitive to 6-OHDA (data not shown). We conclude that mutations in glit-1 or ttr-33 
cause premature degeneration of dopaminergic neurons after 6-OHDA intoxication, likely due 
to reduced gene function.  
So far, it has not been determined at which developmental stages glit-1 and ttr-33 act, but 
oxidative stress assays are usually performed at the L1 larval stage. When intoxicating later 
larval stages with 6-OHDA, the sensitivity of glit-1 and ttr-33 mutants was decreasing and 
adults were not sensitive (Figure 2F). The ttr-33 phenotype is lost even earlier in development 
than the glit-1 phenotype. In summary, the first two larval stages are most strongly affected by 
a mutation in glit-1 or ttr-33. 
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Figure 2: Mutations in glit-1 or ttr-33 cause premature dopaminergic neurodegeneration 
after intoxication with 6-OHDA. 
A) Cartoon of basic C. elegans anatomy and position of dopaminergic neurons: 4 CEP, 2 ADE 
and 2 PDE neurons (highlighted in yellow). Adapted from (Chege and McColl, 2014).  
B) GFP-labelled C. elegans dopaminergic head neurons – 4 CEP neurons and 2 ADE neurons – 
(upper image, ‘Ctr’) and exemplary picture of neurodegeneration after intoxication with 6-
hydroxydopamine (lower image, ‘+6-OHDA’). 
C) Remaining C. elegans dopaminergic head neurons 24, 48 and 72 hours after intoxication 
with 10 mM 6-OHDA and 72 h after treatment with ascorbic acid only (‘72h Ctr’) for BY200 
wild-type or glit-1 and ttr-33 mutant animals. Animals possessing all neurons were scored as 
‘ADE + CEP’ (white bar), those with partial loss of CEP but intact ADE neurons as ‘ADE + partial 
CEP’ (light grey bar), those with complete loss of CEP but intact ADE neurons as ‘only ADE’ 
(dark grey bar) and those with complete loss of dopaminergic head neurons as ‘no ADE + CEP’ 
(black bar). Error bars = S.E.M. of 2 biological replicates for glit-1(ok237) and 3 biological 
replicates for all the other strains, each with at least 60 animals per strain and concentration. 
Total number of animals per condition n = 115-340 (****p<0.0001; G-Test comparing BY200 
wild-type and mutant data of the same time point) − except for the ’72h Ctr’ experiment was 
tested once with n = 30-100.  
D) glit-1 gene structure with positions of the glit-1(gt1981) point mutation, the glit-
1(gk384527) splice site mutation and the glit-1(ok237) deletion. For the point mutations the 
nucleotide and amino acid changes are indicated in brackets. The ok237 deletion spans 5’UTR 
and first exon of glit-1 and 5’UTR and first exons of dnj-14 (DNaJ domain (prokaryotic heat 
shock protein)) and is indicated with a red bar. Also, glit-1 lies in an operon (grey bar) and 
shares a promoter with the ribosomal protein rpl-25.1 (Ribosomal Protein, Large subunit).  
E) ttr-33 gene structure with positions of ttr-33(gt1983) and ttr-33(gk567379)/ttr-33(L72F) 
point mutations. The nucleotide and amino acid changes are indicated in brackets.  
F) Dopaminergic head neurons in wild-type animals and glit-1 and ttr-33 mutants 48 h after 
intoxicating the indicated larval stages (L1-L4) or adult animals with 10 mM 6-OHDA. Error bars 
= SEM of 2 biological replicates, each with at least 25 animals per stage and strain. Total 
number of animals per condition n = 50-75 (****p<0.0001, **p<0.01, n.s. p>0.05; G-Test 
comparing BY200 wild-type and mutant animals data of the same lifecycle stages). 
 
During 6-OHDA intoxication, the whole animal is exposed to the drug; hence it is possible that 
mutants with an increased organismal drug uptake exhibit higher susceptibility. Since 6-OHDA 
causes oxidative stress, a higher drug uptake would be expected to be detrimental for 
organismal health. However, the development of the mutant worms was not compromised or 
retarded after the 6-OHDA assay: glit-1 mutants grew markedly and ttr-33 mutants slightly 
slower than wild-type animals, but this delay was not enhanced by intoxication with 6-OHDA 
(Figure 3A). We noted that mutants with a glit-1 deletion grew much slower than mutants 
carrying glit-1 point mutations. This growth delay could be caused by defects in neighbouring 
genes rpl-25.1 (Ribosomal Protein, Large subunit) and dnj-14 (DNaJ domain (prokaryotic heat 
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shock protein)) that are also affected by the deletion (Figure 2D). There is further support that 
the mutants are not generally sensitive to 6-OHDA, since preventing neuronal drug uptake also 
prevented neuronal loss: a deletion in dat-1, the C. elegans dopamine transporter that shuttles 
6-OHDA into the neurons, rescued dopaminergic neurodegeneration of wild-type worms (Nass 
et al., 2002) and glit-1(gt1981) and ttr-33(gt1983) mutants (Figure 3B). In summary, it is 
unlikely that an increased organismal drug uptake is the mechanism by which the mutants are 
rendered hypersensitive − and glit-1 and ttr-33 mutations are expected to interfere with 
processes that occur after 6-OHDA enters dopaminergic neurons.  
 
 
Figure 3: The mutants are unlikely to exhibit increased organismal drug uptake and 6-OHDA 
must enter dopaminergic neurons to cause dopaminergic neurodegeneration. 
A) Developmental stages of wild-type and mutant L1 stage larvae 48 h after treatment without 
and with 6-OHDA. Worms developed via the L1, L2 (in red), L3 (in orange), L4 (green) and 
young adult stage (in light blue) into adults (in dark blue). Error bars = SEM of 3 biological 
replicates, each with at least 60 animals per concentration and strain. Total number of animals 
per condition n = 200-350 (n.s. p>0.05; G-Test). 
B) Scoring of C. elegans dopaminergic head neurons 72 hours after intoxication with 10 mM 6-
OHDA. Error bars = SEM of 2 experiments, each with at least 50 animals per strain. Total 
number of animals per strain n = 100-400 (****p<0.0001; G-Test). 
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2.2 tsp-17, glit-1 and ttr-33 are sensitive to oxidative stress and short-lived, but 
resistant to endoplasmic reticulum stress 
Oxidative stress elicited by 6-OHDA led to premature death of dopaminergic neurons in glit-1 
and ttr-33 mutants and we wanted to determine if oxidative stress also affects the mutants at 
an organismal level. We also included the tetraspanin mutant tsp-17, which was previously 
shown to be sensitive to 6-OHDA, in the characterisation (Masoudi et al., 2014). We treated 
worms with paraquat, an herbicide which elicits reactive oxygen species (ROS) and which is 
linked to the development of Parkinson ’s disease (Tanner et al., 2011; Wang et al., 2011). 
Paraquat however is not specifically taken up into dopaminergic neurons like 6-OHDA. 
Remarkably, paraquat exposure did not elicit dopaminergic neurodegeneration (data not 
shown), so it is possible that the neurons only die when accumulating high levels of 
intracellular ROS. However, in line with a higher sensitivity to organismal oxidative stress, glit-
1, tsp-17 and ttr-33 showed a reduced survival after paraquat exposure. glit-1 and tsp-17 
exhibited a very strong defect with equal severity, which was more pronounced than the ttr-33 
phenotype (Figure 4A). Hence, glit-1, ttr-33 and tsp-17 show increased sensitivity to 6-OHDA-
induced oxidative stress on the neuronal and to paraquat-induced oxidative stress on the 
organismal level.  
Increased oxidative stress has been implicated with premature aging (Lionaki and 
Tavernarakis, 2013), therefore we determined the lifespan of glit-1 and ttr-33 mutants. We 
found that glit-1, tsp-17 and ttr-33 exhibited shortened lifespans (Figure 4B), indicating that 
the mutants might suffer from malfunctioning stress response pathways on the organismal 
level.  
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Figure 4: glit-1, tsp-17 and ttr-33 are sensitive to oxidative stress, short-lived and resistant to 
ER stress. 
A) Oxidative stress assay: Survival of L1 larvae 24 h after 1 h incubation with indicated 
concentration of paraquat. At 100 mM paraquat, 50% of wild-type animals were dead (data 
not shown). Error bars = SEM of 3 biological replicates, each with at least 80 animals per strain 
and concentration. Total number of animals per condition n = 350-650 (**p<0.02; two-tailed t-
test comparing data of BY200 wild-type and mutant animal data at 50 mM paraquat). 
B) Lifespan assay: Lifespan data shown for second biological replicate. Inset depicts mean 
lifespan and SEM based on 2 biological replicates, each with at least 100 animals. Total number 
of animals per strain n = 200-230 (**Bonferroni p<0.01; Log-Rank Test), except for N2 wild-
type which was tested once with n = 110.  
C) ER stress assay: Development of embryos after 48 h into young adults (YA), L4, L3 or L2 
stage larvae on plates with indicated concentration of tunicamycin. Only dead L1 stage larvae 
could be detected 48 h after egg-laying and were therefore included in the ‘dead’ category. 
Error bars = SEM of 2 biological replicates, each with at least 50 animals per strain and 
concentration. Total number of animals per condition n = 210-400 (****p<0.0001; G-Test) 
D) Hygromycin B assay: Development of L1 larvae 48 h after plating on indicated concentration 
of hygromycin B. Error bars = SEM of 2 biological replicates, each with at least 60 animals per 
strain and concentration. Total number of animals per condition n = 120-330 (**p<0.02, 
*p<0.05, n.s. p>0.05; two-tailed t-test). 
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Changes in oxidative stress response pathways can lead to defects in protein metabolism; 
hence, we analysed if glit-1, ttr-33 and tsp-17 are sensitive to protein folding stress. The 
antibiotic tunicamycin inhibits N-glycosylation of proteins in the ER (Heifetz et al., 1979) and 
triggers the unfolded protein response (UPR) which in turn induces cell cycle arrest. Therefore, 
C. elegans worms grow slower when exposed to tunicamycin. Surprisingly, we found that all 
three mutants were resistant to tunicamycin-induced protein folding stress as the animals 
grew faster than wild-type worms (Figure 4C). Thus, a decrease in oxidative stress resistance 
goes along with an increase in ER stress resistance in glit-1, ttr-33 and tsp-17 mutant animals.  
glit-1, ttr-33 and tsp-17 mutants are sensitive to oxidative stress and resistant to ER stress, 
thus they might exhibit an altered oxidative stress or ER stress response. There are two 
possible explanations why the mutants show resistance to ER stress: 1) The ER UPR could be 
working less efficiently in the mutants, leading to less growth inhibition, or 2) the mutants 
might be pre-conditioned, exhibiting a higher baseline level of the ER UPR and therefore be 
adapted to better deal with additional stress. These two possibilities can be distinguished by 
determining baseline stress response levels using transcriptional reporter lines. Preliminary 
experiments indicated lower expression of the oxidative stress reporter Pgst-4::gfp and higher 
expression of the ER UPR reporter Phsp-4::gfp in glit-1 mutant animals under basal conditions 
(Figure 5). These results indicate the oxidative stress response might be down- and the ER UPR 
stress response upregulated in glit-1 mutants. However, the stress reporter experiments have 
to be repeated for quantification. One of the outcomes of the ER UPR is the inhibition of 
translation. If the UPR is upregulated, a slower organismal growth is expected and we detected 
that glit-1 and ttr-33 mutants are indeed developing slower than wild-type worms (Figure 3A). 
In addition, we tested the reaction to the translation inhibitor hygromycin B, which should lead 
to bigger effects in worms that already exhibit a reduced basal translation rate. We found that 
glit-1, tsp-17 and ttr-33 are more affected by an inhibition of protein translation than wild-type 
worms (Figure 4D), indicating that the UPR might indeed be upregulated in the mutants. In 
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summary, a downregulated or malfunctioning oxidative stress response might render the 
mutants more sensitive to ROS exposure and an upregulated UPR could prepare them for 
additional ER stress under basal conditions.  
 
Figure 5: Indication for reduced basal expression of oxidative stress reporter and elevated 
basal expression of ER UPR stress reporter in glit-1 mutants . 
Preliminary results of oxidative stress reporter Pgst-4::gfp and ER UPR stress reporter Phsp-
4::gfp expression in wild-type and glit-1 mutant animals at L4 stage at basal conditions. 
 
2.3 Known stress response pathways influence 6-OHDA-induced dopaminergic 
neurodegeneration 
glit-1, ttr-33 and tsp-17 mutants exhibit altered organismal stress responses. To determine if 
known C. elegans stress response pathways influence the 6-OHDA-induced neurodegeneration 
of the mutants, we turned to a candidate approach. 
wild-type glit-1
Pgst-4::gfp
Phsp-4::gfp
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Figure 6: Interactions of C. elegans skn-1/Nrf and MAPK stress response pathways tested in 
this study – adapted from (Ewbank, 2006; Inoue et al., 2005). 
Tested genes are shaded in yellow. Stimuli of stress response pathways are shown in red and 
grey and responses of stress response pathways in blue. The MAPKs (mitogen-activated 
protein kinases) pmk-1, kgb-1 and jnk-1 are shown, but not the upstream MAPK kinases and 
the MAPK kinase kinases.  
 
The Nrf (nuclear factor E2-related factor) transcription factor family regulates an oxidative 
stress response in mammals (Sykiotis and Bohmann, 2010) and the C. elegans Nrf orthologue 
skn-1 (SKiNhead) similarly promotes oxidative stress resistance and longevity (An and 
Blackwell, 2003). If skn-1 regulates the stress response after 6-OHDA exposure, the skn-1/Nrf 
loss-of-function mutation zu67 is expected to render dopaminergic neurons hypersensitive to 
the drug. However, a skn-1(zu67) mutation neither led to increased dopaminergic 
neurodegeneration (Figure 7A), nor altered the phenotype of glit-1 mutants after 6-OHDA 
intoxication (Figure 7B). In C. elegans, the abundance of SKN-1 is negatively regulated by the 
CUL-4/DDB-1 ubiquitin ligase substrate targeting protein WDR-23 (WD Repeat protein) (Figure 
6) (Choe et al., 2009; Staab et al., 2013). Hyperactivation of skn-1 activity – conferred by a 
gain-of-function (GOF) mutation in skn-1 or by loss of the skn-1 repressor wdr-23 (Choe et al., 
2009) – led to reduced dopaminergic neurodegeneration in glit-1 mutants (Figure 7F), but also 
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in wild-type worms (Figure 7E). The effect of the wdr-23(tm1817) repressor mutation seemed 
to be stronger than the skn-1(lax120) stimulation alone. In summary, skn-1 hyperactivation 
seems to improve the general organismal stress response, but loss-of-function of skn-1 does 
not lead to increased 6-OHDA-induced neurodegeneration.  
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Figure 7: Boosting the skn-1 oxidative stress pathway alleviates neurodegeneration.  
Dopaminergic neurons were scored 72 h after intoxication with indicated concentration of 6-
OHDA. 
A) and B) Experiment were done with unstarved, filtered L1 larvae since an insufficient amount 
of skn-1(zu67) mutants could be gained in liquid culture. Unstarved worms show a higher 
degree of degeneration. 
A) Effect of skn-1 loss-of-function (lof) allele zu67 in a wild-type background. Error bars = SEM 
of 3 biological replicates, each with at least 30 animals per strain. Total number of animals per 
strain n = 160-270 (n.s. p>0.05; G Test). 
B) Effect of skn-1 loss-of-function (lof) allele zu67 in the glit-1 mutant background. Error bars = 
SEM of 3 biological replicates with each 40-100 scored worms per condition. Error bars = SEM 
of 3 biological replicates, each with at least 40 animals per strain. Total number of animals per 
strain n = 190-310 (n.s. p>0.05; G Test). 
C) Effect of PINK homologue mutation pink-1 and parkin homologue mutation pdr-1 in a wild-
type background. 1 experiment was conducted with a total number of animals per strain n = 
50.  
D) Effect of PINK homologue mutation pink-1 and parkin homologue mutation pdr-1 in the glit-
1 mutant background. Error bars = SEM of 2 biological replicates, each with at least 60 animals 
per strain. Total number of animals per strain n = 120-210 (***p<0.0001, **p<0.01, *p<0.05; 
G-Test). 
E) Effect of skn-1 gain-of-function (gof) mutations skn-1(lax120) and wdr-23(1817) in a wild-
type background. Error bars = SEM of at least 3 biological replicates, each with at least 60 
animals per strain and concentration. Total number of animals per condition = 240-430 
(****p<0.0001, *p<0.05, n.s. p>0.05; G-Test). 
F) Effect of skn-1 gain-of-function (gof) mutations skn-1(lax120) and wdr-23(1817) in the glit-1 
mutant background. Error bars = SEM of at least 3 biological replicates, each with at least 60 
animals per strain and concentration. Total number of animals per condition n = 180-420 
(****p<0.0001, **p<0.01, *p<0.05; G-Test). 
 
Mitophagy, the removal of damaged mitochondria is important for cellular stress resistance 
and the kinase PINK1/pink-1 and the E3 ubiquitin ligase Parkin/pdr-1 initiate C. elegans 
mitophagy in a pathway parallel to skn-1 (Palikaras et al., 2015). In addition, PINK1/pink-1- and 
Parkin/pdr-1-mediated mitophagy is activated in response to mitochondrial stress (Schiavi et 
al., 2015). We used strains carrying pink-1 or pdr-1 mutations to test if the compromise of 
mitophagy leads to an altered 6-OHDA response. However, pink-1 or pdr-1 mutations did not 
lead to premature loss of dopaminergic neurons (Figure 7C) and did not alter the glit-1 mutant 
phenotype (Figure 7D). Therefore, mitophagy does not seem to have a role in 6-OHDA-induced 
neuronal death. 
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The unfolded protein response of the ER (ER UPR) appears upregulated in the mutants, so we 
aimed to investigate if this pathway influences 6-OHDA-induced dopaminergic 
neurodegeneration in C. elegans. IRE1 (inositol-requiring enzyme 1) is a UPR sensor and 
mediates the most conserved branch of the UPR (Urra et al., 2013). Upon ER stress, IRE1 
dimerises, autophosphorylates and activates XBP-1 (X box-binding protein 1) by intron excision 
(Duda et al., 2016). XBP-1 in turn is a transcription factor that mediates the expression of 
proteins involved in folding, ER entry, ER-associated degradation, and ER and Golgi biogenesis 
(Duda et al., 2016). IRE1 has a pro-survival role, sustained IRE1 signalling however might also 
trigger cell death (Urra et al., 2013). The switch between pro-survival and pro-apoptotic phases 
of UPR likely depends on the duration and intensity of the stress stimuli (Urra et al., 2013). We 
find that a mutation in ire-1 did not cause premature dopaminergic neurodegeneration (Figure 
8A, B) and alleviated neurodegeneration in ttr-33 mutants (Figure 8A). In the glit-1 mutant it 
seemed that inhibition of the ER UPR led to slight alleviation of neurodegeneration at a low, 
but not at a higher concentration of 6-OHDA (Figure 8B). Therefore, the unfolded protein 
response seems to be involved in mediating 6-OHDA-induced neurodegeneration in the ttr-33, 
but not in the glit-1 mutant. 
c-Jun N-terminal Kinases (JNKs) and p38 can be activated by cellular stress and are part of the 
mitogen-activated protein kinase (MAPK) superfamily, which plays a central role in immune 
cell activation (Huang et al., 2009). Pro- and anti-apoptotic roles for JNK have been proposed 
(Liu and Lin, 2005), including sustained JNK activation via IRE1 upon ER stress (Tabas and Ron, 
2011) and the promotion of apoptosis after 6-OHDA exposure in a cell-based model of PD 
(Wilhelm et al., 2007). In addition to its role in cell death regulation, JNK might be involved in 
intercellular adhesion (You et al., 2013).  
 
35 
 
 
Figure 8: Abolishing the unfolded protein response alleviates neurodegeneration.  
Dopaminergic neurons were scored 72 h after intoxication with indicated concentration of 6-
OHDA. 
A) Effect of unfolded protein response (UPR) gene mutation ire-1 in the ttr-33 mutant 
background. Error bars = SEM of at least 2 biological replicates, each with at least 50 animals 
per strain and concentration. Total number of animals per condition n = 100-320 
(****p<0.0001, n.s. p>0.05; G-Test). 
B) Effect of unfolded protein response (UPR) gene mutation ire-1 in the glit-1 mutant 
background. Error bars = SEM of at least 2 biological replicates, each with at least 50 animals 
per strain and concentration. Total number of animals per condition n = 190-320 (***p<0.001, 
n.s. p>0.05; G-Test). 
 
The C. elegans JNK family members jnk-1 (Jun N-terminal Kinase) and kgb-1 (Kinase, GLH-
Binding) are involved in the response to organismal stressors. JNK-1 (Jun N-terminal Kinase) is 
needed for a normal oxidative stress response (Oh et al., 2005) and is required for 
mitochondrial proliferation (Artal-Sanz and Tavernarakis, 2009). JNK-1 is expressed solely in 
neurons (Kawasaki et al., 1999), in contrast to KGB-1, which is expressed ubiquitously (Gerke et 
al., 2014; Uno et al., 2013). The kgb-1 mutant exhibits increased sensitivity to protein folding 
stress (Mizuno et al., 2008). In addition, a recently discovered surveillance system – which 
interprets interruption of translation and protein transport as a pathogen attack – depends on 
kgb-1 and inhibits the ER UPR (Runkel et al., 2013). 
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Figure 9: Loss of jnk-1 stress response signalling worsens neurodegeneration in ttr-33 
mutants. 
Dopaminergic neurons were scored 72 h after intoxication with indicated concentration of 6-
OHDA. 
A) Effect of p38 and JNK stress response pathway mutations in the ttr-33 mutant background. 
Error bars = SEM of at least 2 biological replicates, each with at least 100 animals per strain 
and concentration. Total number of animals per condition n = 200-430 (***p<0.001, *p<0.05, 
n.s. p>0.05; G-Test). 
B) Effect of p38 and JNK stress response pathway mutations in the glit-1 mutant background. 
Error bars = SEM of at least 2 biological replicates, each with at least 50 animals per strain and 
concentration. Total number of animals per condition n = 140-330 (n.s. p>0.05; G-Test). 
 
pmk-1 (p38 MAP Kinase family) and pmk-3 each form a p38 MAPK pathway in C. elegans. pmk-
1 mediates resistance to bacterial pathogens as part of the innate immune response (Aballay 
et al., 2003; Bolz et al., 2010; Kim et al., 2002; Shivers et al., 2010; Troemel et al., 2006). In 
addition, pmk-1 is needed for ER resistance (Judy et al., 2013; Richardson et al., 2011). Finally, 
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pmk-1 has been shown to stimulate skn-1 activity (Inoue et al., 2005), and a crosstalk between 
the pmk-1 p38 MAPK and the JNK-like kgb-1 pathway has been shown in C. elegans (Kim et al., 
2004; Mizuno et al., 2004). pmk-3 in contrast is needed for axon regeneration (El Bejjani and 
Hammarlund, 2012) and prevents excessive germ cell apoptosis (Lettre et al., 2004). 
MAPK response pathway single mutants (jnk-1, kgb-1, pmk-1, pmk-3) did not lead to 
premature dopaminergic neurodegeneration when intoxicated with 10 mM 6-OHDA (Figure 
9A, B). Therefore, these pathways do not seem to mediate protection against 6-OHDA in the 
wild-type background. However, mutation of jnk-1 led to increased neurodegeneration at both 
tested concentrations in ttr-33 (Figure 9A), but not glit-1 mutants (Figure 9B). Therefore, the 
JNK kinase JNK-1 – for which roles in the defence against oxidative stress have been reported – 
protects ttr-33 mutants from further neurodegeneration.  
In summary, we tested mutants from several C. elegans stress response pathways for their role 
in 6-OHDA-induced neurodegeneration. However, none of the tested mutants – skn-1 being 
part of an oxidative stress response, ire-1 mediating an unfolded protein response and MAP 
kinases regulating diverse stress responses – exhibited an increased sensitivity to 6-OHDA 
similar to glit-1, ttr-33 or tsp-17. Hence, either the genes we identified are involved in 
previously unidentified pathways providing protection against 6-OHDA or alternatively, the 
pathways might act in a redundant manner.  
2.4 glit-1 and tsp-17 might act in the same pathway 
Mutations in glit-1, ttr-33 or tsp-17 render C. elegans dopaminergic neurons hypersensitive to 
6-OHDA, so we asked if the genes could act in the same pathway. Double and triple mutants 
were generated to test epistasis, i.e. to determine if the hypersensitivity phenotypes of the 
single mutants would add up – as expected for different pathways – or if the dopaminergic 
neurons degenerate to a similar extent in the single, double and triple mutants – as predicted 
if the genes were in the same pathway. We found that glit-1 and tsp-17 might act in the same 
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pathway since the glit-1;tsp-17 double mutant was equally hypersensitive as the glit-1 and tsp-
17 single mutants (Figure 10). Reminiscent of the previously described paraquat oxidative 
stress assay (Figure 4B), glit-1 and tsp-17 mutants were equally sensitive and both showed a 
much stronger phenotype than ttr-33 mutants. glit-1 and tsp-17 mutants also showed a very 
similar extent of neurodegeneration when distinct developmental stages of C. elegans worms 
were intoxicated – except that tsp-17 mutants at the L4 stage seemed to be equally sensitive 
as the L3 stage (Figure 2F)(Masoudi et al., 2014). ttr-33 mutants instead only showed very little 
degeneration at the concentration at which glit-1 and tsp-17 mutants had their highest 
sensitivity window, so additive effects between the ttr-33 and glit-1 or tsp-17 mutations 
cannot be unequivocally distinguished from phenotypic fluctuations. Increasing the 
concentration would lead to full degeneration in glit-1 and tsp-17 mutants, so again additive 
effects with a ttr-33 mutation would not be visible. We conclude that glit-1 and tsp-17 likely 
act in a single genetic pathway. 
 
Figure 10: Interplay between glit-1, tsp-17 and ttr-33 mutations and sensitivity of different 
larval stages. 
Dopaminergic head neurons scoring in wild-type and glit-1, tsp-17 and ttr-33 single, double and 
triple mutants 24, 48 and 72 h after intoxication with 0.75 mM 6-OHDA and 72 h after 
treatment with ascorbic acid only (‘72 h Ctr’). Error bars = SEM of 3 biological replicates, each 
with at least 60 animals per strain. Total number of animals per condition n = 180-350 
(*p<0.05, n.s. p>0.05; G-Test) − except for the ’72 h Ctr’ which was conducted twice with 30 
worms per strain, resulting in a total n = 60.  
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3 INTRODUCTION NEUROLIGIN-LIKE GLIT-1 
3.1 Neuroligins 
Neuroligins are postsynaptic cell adhesion proteins required for the correct maturation and 
function of synapses (Varoqueaux et al., 2006). The neuroligin family of proteins is defined by 
an extracellular carboxyesterase-like domain that is enzymatically inactive and that mediates 
binding to the presynaptic neurexins (Hu et al., 2015) (Figure 11). In mammals, neuroligin 
subtypes display unique localisations at excitatory and inhibitory synapses (Bemben et al., 
2015) and neuroligins and neurexins influence the balance of these synapse types in neuronal 
circuits (Calahorro, 2014). Neuroligin and neurexin dysfunction leads to impairment of synaptic 
properties and disruption of neural networks, and neuroligin and neurexin mutations are 
associated with autism and other cognitive diseases (Südhof, 2008).  
 
Figure 11: Model of neuroligin-neurexin interaction at the synapse – from (Araç et al., 2007). 
A postsynaptic neuroligin dimer (in magenta and yellow) binds to a presynaptic neurexin 
dimer (in orange and blue). Two views of the interaction are shown with a 90° angle 
difference.  
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Neuroligins have a conserved WW-binding domain and a PDZ (PSD95, Dlg1, Zo-1) binding 
sequence at their C-terminus and occur as dimers, if not as higher-order oligomers (Bemben et 
al., 2015). There is evidence for direct interactions (Bemben et al., 2015), but the canonical 
model is that scaffolding molecules link neuroligin to receptors at the synapse – e. g. by 
binding via their PDZ domain. The neuroligin-neurexin junction based on PDZ domain protein 
binding resembles the architecture of tight junctions (Südhof, 2008).  
The properties of neuroligins might be influenced by synaptic activity and the accompanying 
calcium signalling. Ca2+-binding EF-hand motifs are common in neuroligins (Tsigelny et al., 
2000) and Ca2+ influences synapse density via neuroligin-1 in mice (Bemben et al., 2015). Also, 
neuroligins and neurexins interact in a Ca2+-dependent manner (Araç et al., 2007; Fabrichny et 
al., 2007; Ichtchenko et al., 1995; Nguyen and Südhof, 1997). Furthermore, neuroligin-1 can be 
cleaved in a Ca2+-dependent manner, resulting in a reduction of synaptic transmission (Peixoto 
et al., 2012). Finally, neuroligin-1 activity-dependent cleavage by ADAM10 generates a 
secreted extracellular neuroligin form and an intracellular fragment which is subsequently 
cleaved by presenilin/γ-secretase (Suzuki et al., 2012). 
3.2 C. elegans neuroligins 
nlg-1 is the only reported C. elegans neuroligin and predominantly expressed in neurons 
(Hunter et al., 2010). NLG-1 acts at the synapse and influences behavioural phenotypes. At 
neuromuscular junctions, NLG-1 and the C. elegans neurexin NRX-1 mediate inhibition of 
neurotransmitter release (Hu et al., 2012) and control postsynaptic GABA receptor clustering 
together with MADD-4 (Muscle Arm Development Defective) (Maro et al., 2015; Tu et al., 
2015). MADD-4 is a secreted protein with predicted metalloprotease activity and physically 
interacts with the extracellular domains of NLG-1 and NRX-1 (Maro et al., 2015; Tu et al., 
2015). nlg-1 mutants show defects in various behaviours, including the ‘basal slowing 
response’ that is mediated by dopamine (Calahorro et al., 2009; Hunter et al., 2010; Izquierdo 
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et al., 2013). nlg-1 seems to act together with nrx-1 to mediate some of its behavioural 
functions, as a nlg-1 mutant defect could be rescued by nrx-1 mutation (Calahorro et al., 
2009). The conservation of neuroligins is emphasised by the fact that basal slowing response 
phenotype of the nlg-1 mutant is alleviated by expression of human neuroligin-1 (Izquierdo et 
al., 2013).  
C. elegans nlg-1 also forms part of an organismal stress response. The abundance of synaptic 
NLG-1 is transcriptionally induced by the oxidative stress ‘master regulator’ SKN-1 to promote 
organismal survival (Staab et al., 2014). In line with this, nlg-1 mutants are short-lived (Hunter 
et al., 2010), sensitive to oxidative stress (Hunter et al., 2010; Staab et al., 2014) and possess 
higher levels of protein carbonylation, a phenotype which is increased by oxidative stress 
exposure (Hunter et al., 2010).  
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4 RESULTS GLIT-1 
4.1 glit-1 encodes a neuroligin-like gene 
Mutations in the so far uncharacterised C. elegans neuroligin-like gene glit-1 (GLIoTactin 
(Drosophila neuroligin-like)) cause hypersensitivity to oxidative stress and resistance against ER 
stress. The predicted GLIT-1 protein structure is similar to those of mammalian neuroligins and 
contains a single-pass transmembrane domain (Figure 12A, B) and an extracellular 
carboxyesterase-like domain. The carboxyesterase domain lacks the conserved catalytic triad 
residues characteristic of acetylcholinesterases but instead features two aspartates, a 
configuration reminiscent of aspartyl proteases (Figure 12 B). In glit-1(gt1981) mutants, a 
proline residue in the carboxyesterase domain is substituted by leucine (Figure 13C). This 
proline residue is conserved in neuroligins and acetylcholinesterases (Figure 12 B), hence the 
P113L substitution in the neuroligin-like glit-1(gt1981) likely interferes with an important 
protein function.  
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Figure 12: GLIT-1 protein architecture and conservation of residues. 
A) GLIT-1 signal peptide (in red), transmembrane domain (in grey) and cytoplasmic/non-
cytoplasmic part (in green and blue, respectively) prediction by Phobius 
(http://phobius.sbc.su.se/). 
B)-C) Visualisation of conservation score is shown at the bottom of each alignment.  
B) Alignment of the human acetylcholinesterase and neuroligin 4 and C. elegans 
acetylcholinesterase ACE-1, neuroligin NLG-1 and neuroligin-like GLIT-1. Carboxyesterase and 
transmembrane domain are indicated with an arrow.  
C) Magnification of alignment in B) to show conservation of the proline residue mutated in 
gt1981 (P113L) and non-conservation of the serine (S), histidine (H) and glutamate (E) residues 
that form part of the catalytic triad of acetylcholinesterases. High conservation is indicated in 
red and low conservation in blue. 
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Based on its categorisation as a neuroligin-like protein, GLIT-1 should be phylogenetically 
closer to neuroligins than to acetylcholinesterases. Indeed, in a phylogenetic tree based on 
human, mouse, Drosophila and C. elegans neuroligins and acetylcholinesterases, GLIT-1 groups 
with its Drosophila homologue gliotactin and close to invertebrate neuroligins (Figure 13A, B). 
The glit-1 Drosophila homologue gliotactin is localised at tricellular junctions (Schulte et al., 
2006) and necessary for the development of septate junctions, an invertebrate analogue of 
tight junctions in epithelial cells (Genova and Fehon, 2003; Schulte et al., 2006). Thyroglobulin, 
a glit-1 human orthologue according to Panther (Protein ANalysis THrough Evolutionary 
Relationships) also possesses a carboxyesterase domain and was included in the tree but does 
not group close to GLIT-1. This is not unexpected since thyroglobulin is a vertebrate-specific 
protein (Holzer et al., 2016). We note however that thyroglobulin is a precursor of thyroid 
hormones which are transported by transthyretin, an orthologue of C. elegans ttr-33. In 
addition, thyroglobulin folds an dimerises in the endoplasmic reticulum (ER) and a defect in ER 
export leads to ER storage disease (Kim et al., 1998). In summary, the phylogenetic analysis 
confirms the classification of GLIT-1 as a neuroligin-like protein. 
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Figure 13: gt1981 is located in the cholinesterase domain of the neuroligin-like protein glit-1. 
A) Phylogenetic tree of acetylcholinesterases and neuroligins from C. elegans, Drosophila, 
mouse and human, gliotactin from Drosophila and thyroglobulin from mouse and human. 
Bootstrap values are indicated in red on top of the branches. ACE = Acetylcholinesterase, Ce = 
C. elegans, Dm = Drosophila melanogaster, Hm = Homo sapiens, Mm = Mus musculus, NLG = 
Neuroligin. 
B) Enlargement of centre part of phylogenetic tree in A). Bootstrap values are indicated in red 
on top of the branches.  
C) GLIT-1 protein structure prediction based on homology modelling with acetylcholinesterase 
(PDB ID: 2W6C). The gt1981 point mutation leads to a proline to glycine conversion (P113G) 
and is indicated in red. The amino acids which now reside at the position of the previous 
catalytic triad are indicated in blue.  
 
4.2 Genetically, glit-1 does not act via neurexin but GLIT-1 PDZ domain 
interactors can be predicted  
Neuroligins modulate signalling by contacting pre-synaptic neurexins (Südhof, 2008). 
Therefore we asked if the C. elegans neurexin nrx-1 protects dopaminergic neurons from 6-
OHDA-induced neurodegeneration as the neuroligin-like glit-1. In C. elegans and higher 
organisms there are many neurexin isoforms due to alternative splicing (Calahorro, 2014) 
(Figure 14D). We acquired two strains with deletions in the only C. elegans neurexin nrx-1, 
ok1649 affecting only the long isoform and wy778 affecting the long and short isoforms of the 
gene (Figure 14D). However, neither of the two nrx-1 deletions led to premature loss of 
dopaminergic neurons after exposure to 6-OHDA (Figure 14A). The nrx-1(ok1649) mutation 
slightly alleviated neurodegeneration of glit-1 mutants (Figure 14A), but also in wild-type 
worms (Figure 14B). Hence, glit-1 is a neuroligin-like gene but does not seem to act with the 
neurexin nrx-1 to prevent dopaminergic neuron death. 
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Figure 14: C. elegans neuroligin and neurexin mutations do not lead to premature 
dopaminergic neurodegeneration. 
Dopaminergic head neurons were scored 72 h after intoxication with indicated concentration 
of 6-OHDA. 
A) Effects of neuroligin and neurexin mutations on dopaminergic neurodegeneration in the 
glit-1 mutant. Error bars = SEM of 2 biological replicates, each with at least 75 animals per 
strain and concentration. Total number of animals per condition n = 150-220 (****p<0.0001, 
**p<0.01, n.s. p>0.05; G-Test). 
B) Effect of neurexin nrx-1(ok259) mutation on dopaminergic neurodegeneration in wild-type 
animals. Error bars = SEM of 2 biological replicates, each with at least 80 animals per strain and 
concentration. Total number of animals per condition n = 170-220 (*p<0.05, n.s. p>0.05; G-
Test). 
C) C. elegans neuroligin nlg-1 gene structure with indicated ok259 deletion site.  
D) C. elegans neurexin nrx-1 gene structure with indicated deletion sites ok1649 and wy778.  
 
Like mammalian neuroligins and C. elegans NLG-1, GLIT-1 contains a short intracellular domain 
(Figure 12A) with a C-terminal PDZ-binding motif, which might be bound by PDZ (PSD95, Dlg1, 
Zo-1) domain proteins. PDZ-domain containing interactors can be predicted based on the 
sequence and structure of the PDZ-binding motif (Hui and Bader, 2010; Hui et al., 2013). The 
sequence-based prediction was made by a machine-learning algorithm that was trained with 
large scale PDZ protein-binding data (Hui and Bader, 2010), whereas the algorithm was trained 
with PDZ domain structures and peptide sequence information for the structure-based 
prediction (Hui et al., 2013). Based on the last five amino acids of GLIT-1 (RITNL), potential 
GLIT-1 binding proteins were determined (Table S 1, Table S 2). Candidates include SHN-1 
(SHANK (SH3/Ankyrin domain scaffold protein) related) − a mammalian homologue of which 
was proposed to form a complex with neuroligin and neurexin (Südhof, 2008)) − and DLG-1 
(Drosophila Discs LarGe homolog) − the Drosophila homologue of which forms a complex with 
the GLIT-1 homologue gliotactin (Schulte et al., 2006) (Table S 1 and Table S 2). These PDZ 
domain-containing proteins are obvious candidates to test for their role in mediating GLIT-1 
functions.  
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4.3 glit-1 mutants show defects in dopamine-associated behaviours 
The C. elegans neuroligin mutant nlg-1 displays defects in dopamine-mediated behaviours 
(Izquierdo et al., 2013), so we aimed to analyse if a mutation in the neuroligin-like glit-1 
interferes with dopamine signalling (Figure 15E) as well.  
To analyse if dopamine signalling is functional in the glit-1 and ttr-33 mutants, we turned to 
the basal slowing response assay. C. elegans worms slow down when encountering a lawn with 
bacterial food, a behaviour that is mediated by dopamine (Sawin et al., 2000). In contrast to 
the tyrosine hydroxylase mutant cat-2 (abnormal catecholamine distribution) which is 
defective in dopamine synthesis, glit-1 and ttr-33 mutants moved slower on plates with 
bacteria than on empty plates (Figure 15D) and the same has been shown before for tsp-17 
(Masoudi et al., 2014). Since glit-1, ttr-33 or tsp-17 mutants did not exhibit a compromised 
basal slowing response, dopamine signalling does not appear decreased in these strains. 
In C. elegans, dopamine regulates acetylcholine release in motor neurons, which in turn 
stimulates muscle action (Figure 15E) (Chase and Koelle, 2007). Hence, when animals are 
exposed to increasing concentrations of exogenous dopamine in the ‘dopamine paralysis 
assay’, this eventually leads to inhibition of acetylcholine release and muscle paralysis (Sanyal 
et al., 2004). Animals with a higher level of intrinsic dopamine signalling are expected to 
paralyse at lower concentration of exogenous dopamine and vice versa. We found that glit-1 
and tsp-17 mutants, but not ttr-33 mutants, stopped moving at lower dopamine 
concentrations than wild-type animals (Figure 15A). In support of increased endogenous 
dopamine signalling, glit-1 mutants showed reduced egg-laying (Figure 15B), a behaviour 
which is inhibited by dopamine (Schafer and Kenyon, 1995). A previous study showed 
increased dopamine uptake for neurons from tsp-17 mutant neurons, suggesting that the 
accompanying higher 6-OHDA uptake causes hypersensitivity against the drug (Masoudi et al., 
2014). Since a higher dopamine uptake might be a secondary effect of a higher dopamine 
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release, it is possible that glit-1 and tsp-17 act via a similar mechanisms. However, the tsp-17 
single mutant paralysed at a lower dopamine concentration than the glit-1 single mutant 
(Figure 15A). In addition, the phenotype of the glit-1;tsp-17 double mutant was stronger 
compared to the respective single mutants. Thus, there might be two at least partially additive 
mechanisms causing increased dopamine release in glit-1 and tsp-17 mutants. 
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Figure 15: Dopamine-mediated behaviours are altered in glit-1 and tsp-17, but not ttr-33 
mutants. 
A) Dopamine paralysis assay: Ability of young adult animals to move on plates with indicated 
concentrations of dopamine. Error bars = StDev of 2 technical replicates, each with 25 animals 
per strain and condition. Total number of animals per condition n = 50 (***p<0.001, **p<0.02, 
n.s. p>0.05; two-tailed t-test comparing wild-type and mutant animal data at 25 mM 
dopamine).  
B) Egg-laying assay (done by Eline Jongsma): Number of eggs per worm per hour. Error bars = 
StDev of 3 technical replicates, each with 3 animals laying at least 45 eggs. A total number of 9 
animals laid a total number of eggs per strain n = 140-171 (n.s. p>0.05; two-tailed t-test).  
C) Swimming-induced paralysis (SWIP) assay: Ability of L4 stage animals to swim in a drop of 
water. Error bars = SEM of at least 3 biological replicates with at least 12 animals per strain. 
Total number of animals per strain n = 50-60 (*p<0.05, n.s. p>0.05; two-tailed t-test comparing 
wild-type and mutant data at 30 min time point).  
D) Basal slowing response (done by Eline Jongsma): Ability of young adult animals to slow 
down on a lawn of bacteria. The tyrosine hydroxylase mutant cat-2 (abnormal catecholamine 
distribution) is deficient of dopamine synthesis. Error bars = SEM of 2 biological replicates, each 
with 6 animals per strain and state. Total number of animals per condition n = 12 
(****p<0.0001, n.s. p>0.05; two-tailed t-test).  
E) Dopamine signalling cartoon. Dopaminergic (DAergic) neurons are stimulated by food. 
Dopamine synthesis starts with tyrosine (Tyr), which is converted to L-DOPA (L-3,4-
dihydroxyphenylalanine) by the tyrosine hydroxylase cat-2 (abnormal catecholamine 
distribution) and then to dopamine (DA) by the aromatic amino acid decarboxylase bas-1 
(biotenic amine synthesis related). Dopamine is packed into vesicles by the vesicular 
monoamine transporter cat-1. Postsynaptic dopamine signalling is stimulated by the the D1-
like dopamine receptor dop-1 and inhibited by the D2-like dopamine receptor dop-3. The D2-
like receptor dop-2 can also be postsynaptic or presynaptic and acts as an autoreceptor. The 
D1-like (stimulatory) and the D2-like (inhibitory) dopamine receptors are indicated in blue and 
red, respectively. Dopamine is transported back into the dopaminergic neurons via the 
dopamine transporter dat-1. Cholinergic neurons signal via the neurotransmitter ACh 
(acetylcholine) which in turn stimulates muscle action.  
 
A second approach to test for excessive dopamine signalling is the swimming-induced paralysis 
(SWIP) assay. Here, worms are put in a drop of water to monitor their swimming behaviour. 
Mutants with higher extrasynaptic dopamine concentrations, like the dopamine transporter 
mutant dat-1, exhibit premature paralysis (McDonald et al., 2007). Also tsp-17 mutants have 
been shown to exhibit premature paralysis (Masoudi et al., 2014), but glit-1 mutants did not 
paralyse earlier than wild-type worms (Figure 15C). Animals with the glit-1(ok237) deletion 
seemed to swim even longer than wild-type animals; however, this mutation affects also two 
neighbouring genes that could cause these effects. Taken together, the dopamine paralysis 
assay and the SWIP assay suggest that the dopamine signalling defects in glit-1 mutants might 
52 
 
be much smaller than in tsp-17 mutants, and can therefore not be detected in the SWIP assay. 
Alternatively, glit-1 and tsp-17 might have different mechanisms of action to interfere with 
dopamine release. 
4.4 Interference with dopamine metabolism increases glit-1 dopaminergic 
neurodegeneration 
glit-1 mutants showed signs of higher intrinsic dopamine signalling and we wanted to address 
if this could be the reason for their sensitivity to 6-OHDA. If a change in dopamine metabolism 
is the cause for glit-1 mutant hypersensitivity, interference with dopamine metabolism (Figure 
15E) is expected to alter the glit-1 phenotype. We find that mutation of the tyrosine 
hydroxylase cat-2 highly, and mutation of the vesicular monoamine transporter cat-1 slightly 
augmented dopaminergic neurodegeneration of glit-1 mutants (Figure 16B). This 
enhancement was specific for glit-1, since degeneration of wild-type animals was not 
increased by cat-2, and might even be decreased by cat-1 (Figure 16C). Mutation of the 
aromatic amino acid decarboxylase bas-1, which is also part of the dopamine synthesis 
pathway, did not modulate glit-1 sensitivity. Yet importantly, out of the three tested enzymes, 
cat-2 is the one specific for dopamine synthesis since bas-1 also functions in serotonin 
production and cat-1 also mediates vesicle packing in serotonergic, tyraminergic and 
octopaminergic neurons (Chase and Koelle, 2007). CAT-1 mediates synaptic vesicle packing, 
thus a cat-1 mutation might lead to increased cytosolic dopamine levels which were shown to 
be detrimental for dopaminergic neurons. A mutation in cat-2 in contrast leads to decreased 
dopamine synthesis and as a result, a 6-OHDA/dopamine ratio should be tilted in favour of 6-
OHDA. Since both dopamine and 6-OHDA compete for entry into dopaminergic neurons via 
dat-1, a higher proportion of 6-OHDA entering the cell could explain the increased sensitivity 
of glit-1;cat-2 mutants. In line with this argument, CAT-2 overexpression was shown to 
diminish 6-OHDA-induced dopaminergic neurodegeneration, likely because of increased 
dopamine synthesis (Masoudi et al., 2014). Alternatively, defects in dopamine synthesis might 
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cause additional cellular stress, leading to decreased resistance to 6-OHDA. In summary, we 
find that a decrease in dopamine synthesis or vesicle packing leads to an increased loss of 
dopaminergic neurons in glit-1 mutants. 
Dopamine acts by binding to the D1-type (stimulatory) dopamine receptor dop-1 and the D2-
type (inhibitory) dopamine receptors dop-2 and dop-3 and we aimed to investigate if the 
downstream signalling mediated by these receptors affects the glit-1 phenotype. We found 
that mutation of dop-2 decreased the sensitivity of glit-1 mutants (Figure 16A), however this is 
also true for wildtype worms (Figure 16C). Studies in mice and cell culture indicate that D2-type 
receptors regulate activity and cell surface expression of the dopamine transporter (Bolan et 
al., 2007; Lee et al., 2007b) and pharmacological inhibition of D2 class dopamine receptors in 
rats was shown to inhibit dopamine transporter function (Cass and Gerhardt, 1994). Similarly, 
mutation of the C. elegans D2-type dopamine receptor dop-2 might lead to a decrease in 
dopamine transporter activity. This is expected to lead to decreased 6-OHDA uptake and thus 
reduced 6-OHDA toxicity in dopaminergic neurons. C. elegans dop-2 was reported to act as a 
D2-type presynaptic dopamine autoreceptor and to stimulate dopamine release (Suo et al., 
2003; Voglis and Tavernarakis, 2008). This suggests an alternative explanation for the reduced 
6-OHDA toxicity in dop-2 mutant animals: decreased amounts of extracellular dopamine 
competing for cellular entry via the dopamine transporter would also lead to a higher amount 
of toxic 6-OHDA being able to enter the neuron.  
54 
 
 
0%
20%
40%
60%
80%
100%
BY
20
0
w
ild
-t
yp
e
gl
it-
1(
gt
19
81
)
do
p-
1(
vs
10
0)
gl
it-
1;
do
p-
1
do
p-
2(
vs
10
5)
do
p-
2;
gl
it-
1
do
p-
3(
vs
10
6)
gl
it-
1;
do
p-
3
do
p-
2;
do
p-
1
do
p-
2;
do
p-
1;
gl
it-
1
do
p-
1;
do
p-
3
do
p-
1;
gl
it-
1;
do
p-
3
do
p-
2;
do
p-
3
do
p-
2;
gl
it-
1;
do
p-
3
do
p-
2;
do
p-
1;
do
p-
3
do
p-
2;
do
p-
1;
gl
it-
1;
do
p-
3
0.75 mM 6-OHDA
ADE + CEP ADE + partial CEP only ADE no ADE + CEPA
0%
20%
40%
60%
80%
100%
120%
BY
20
0
w
ild
-t
yp
e
do
p-
2(
vs
10
5)
ca
t-1
(o
k4
11
)
ca
t-2
(e
11
12
)
50 mM 6-OHDA
C
B
0%
20%
40%
60%
80%
100%
BY
20
0
gl
it-
1(
gt
19
81
)
do
p-
1(
vs
10
0)
do
p-
1;
gl
it-
1
do
p-
2(
vs
10
5)
do
p-
2;
gl
it-
1
do
p-
3(
vs
10
6)
gl
it-
1;
do
p-
3
do
p-
2;
do
p-
1
do
p-
2;
do
p-
1;
gl
it-
1
do
p-
1;
do
p-
3
do
p-
1;
gl
it-
1;
do
p-
3
do
p-
2;
do
p-
3
do
p-
2;
gl
it-
1;
do
p-
3
do
p-
2;
do
p-
1;
do
p-
3
do
p-
2;
do
p-
1;
gl
it-
1;
do
p-
3
10 mM 6-OHDA
0%
20%
40%
60%
80%
100%
BY
20
0
gl
it-
1(
gt
19
81
)
ba
s-
1(
ad
44
6)
ba
s-
1;
gl
it-
1
ca
t-1
(o
k4
11
)
gl
it-
1;
ca
t-1
ca
t-2
(e
11
12
)
ca
t-2
;g
lit
-1
10 mM 6-OHDA
0%
20%
40%
60%
80%
100%
120%
BY
20
0
w
ild
-t
yp
e
do
p-
2(
vs
10
5)
ca
t-1
(o
k4
11
)
ca
t-2
(e
11
12
)
25 mM 6-OHDA
0%
20%
40%
60%
80%
100%
BY
20
0
w
ild
-t
yp
e
gl
it-
1(
gt
19
81
)
ba
s-
1(
ad
44
6)
ba
s-
1;
gl
it-
1
ca
t-1
(o
k4
11
)
gl
it-
1;
ca
t-1
ca
t-2
(e
11
12
)
ca
t-2
;g
lit
-1
0.75 mM 6-OHDA
n.s.
***
*n.s.** ***
n.s.
***n.s.****** n.s.
**
**
n.s. ****
****
n.s.
n.s.
**** ***
n.s. n.s.
***
55 
 
Figure 16: Interference with dopamine synthesis and vesicle packing increases glit-1 
dopaminergic neurodegeneration. 
Dopaminergic neurons were scored 72 h after intoxication with indicated concentration of 6-
OHDA.  
A) Effect of dopamine receptor mutations on dopaminergic neurodegeneration in the glit-1 
mutant background. Error bars = SEM of 3 biological replicates, each with at least 60 animals 
per strain and concentration. Total number of animals per condition n = 180-330 
(****p<0.0001, ***p<0.001, **p<0.01, *p<0.05, n.s. p>0.05; G-Test comparing glit-1 mutant 
data to double and triple mutant data). A significant p-value is only indicated if all or all but 
one replicate were found to be significant. 
B) Effect of mutations in dopamine metabolism genes on dopaminergic neurodegeneration in 
the glit-1 mutant background.  
Error bars = SEM of 3 biological replicates, each with at least 60 animals per strain and 
concentration. Total number of animals per condition n = 180-330 (****p<0.0001, 
***p<0.001, n.s. p>0.05; G-Test comparing glit-1 mutant data to double mutant data). 
C) Effect of mutations in the dopamine receptor dop-2 and the dopamine metabolism genes 
cat-1 and cat-2 on dopaminergic neurodegeneration in a wild-type background. 
Error bars = SEM of 3 biological replicates, each with at least 60 animals per strain and 
concentration. Total number of animals per condition n = 180-330 (****p<0.0001, **p<0.02, 
n.s. p>0.05; G-Test comparing BY200 wild-type to mutant animal data). A significant p-value is 
only indicated if all or all but one replicate were found to be significant. 
dop-1, dop-2, dop-3 = dopamine receptors, bas-1 (biotenic amine synthesis related) = aromatic 
amino acid decarboxylase, cat-1 (abnormal catecholamine distribution = the vesicular 
monoamine transporter, cat-2 (abnormal catecholamine distribution) = tyrosine hydroxylase.  
 
4.5 glit-1 is expressed in pharynx, intestine and possibly dopaminergic neurons 
glit-1 genetically interacts with cat-2, the key enzyme of dopamine synthesis, and mutation of 
glit-1 partially phenocopies mutation of tsp-17, a gene shown to function in dopaminergic 
neurons (Masoudi et al., 2014). Several constructs were created to determine where glit-1 
acts. Unfortunately, a C-terminal CRISPR-Cas9 GFP insertion at the glit-1 locus seemed to 
render the protein non-functional: No GFP expression was visible and the GFP-tagged gene 
was not able to rescue the glit-1(gt1981) mutant phenotype, glit-1(gt1981)/glit-1::gfp animals 
were still sensitive to 6-OHDA (data not shown). In parallel, a Pglit-1::gfp transcriptional 
construct for targeted chromosomal insertion was made. In five independent lines, GFP 
expression was detected in animals carrying the non-integrated and therefore stochastically 
inherited PExglit-1::GFP construct. Expression was visible in the pharynx, intestine and possibly 
the neurons of L1 larvae – the developmental stage most sensitised to 6-OHDA in the glit-1 
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mutant (Figure 17A, B). In adult animals, dopaminergic neurons seemed to express the Pglit-
1::gfp construct (Figure 17C, D), however adults were not sensitive to 6-OHDA (Figure 10B). 
Importantly, glit-1 is in an operon with rpl-25.1 and shares its promoter region with dnj-14, 
which is situated on the other strand (Figure 2D). Therefore, a Pglit-1::gfp transcriptional 
reporter construct automatically includes parts of those other promoters that could also drive 
expression, so only cautious interpretations can be made. In summary, GLIT-1 is expressed in 
pharynx and intestine and possibly in dopaminergic neurons.  
 
57 
 
 
Figure 17: glit-1 is expressed in pharynx and intestine and might be expressed in 
dopaminergic neurons. 
Animals expressing the extrachromosomal, transcriptional PExglit-1::GFP construct in the 
background of Pdat-1::RFP which labels nuclei of dopaminergic neurons. 
A) L1 stage larva. 
B) L1 stage larva. 
C) CEP-neuron containing head region of adult animal. 
D) ADE-neuron containing head region of same adult animal. 
 
PExglit-1::GFP Pdat-1::NLS::RFP
L1 stage larva L1 stage larva
Adult CEP neurons Adult ADE neurons
A B
C D
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5 INTRODUCTION TRANSTHYRETIN-RELATED TTR-33 
5.1 Transthyretin, transthyretin-like and transthyretin-related proteins 
ttr-33 belongs to the nematode-specific family of transthyretin-related proteins, which likely 
arose from a duplication of an ancestral transthyretin-like family (Jacob et al., 2007), similar to 
the vertebrate-specific transthyretins (Richardson, 2015).  
Transthyretin (transporter of thyroxine (T4) and retinol) transports thyroid hormones and 
retinol, in the latter case through binding to retinol-binding protein, and is associated with 
amyloid diseases (Alshehri et al., 2015). The ancestral transthyretin-like family has 
characteristic residues to hydrolyse a product of uric acid oxidation, however these are lost in 
transthyretin (Richardson, 2015). Transthyretin is mainly synthesised in the liver and the 
choroid plexus of the brain (Alshehri et al., 2015) – a branching network of cells that produces 
the cerebrospinal fluid. The pathological deposition of transthyretin can cause amyloid 
diseases: wild-type transthyretin is connected to age-dependent senile systemic amyloidosis 
(SSA), whereas mutant transthyretin is associated with autosomal dominant familial amyloid 
polyneuropathy (FAP) which leads to axonal loss and neuronal death in peripheral nerves 
(Richardson and Cody (Eds.), 2009). FAP mutations destabilise the transthyretin homotetramer 
(McCutchen et al., 1993, 1995). However, there are protective ‘trans-suppressor’ transthyretin 
mutations that counteract this destabilisation (Hammarström et al., 2001) similarly to several 
inhibitors of transthyretin amyloidosis (Hammarström et al., 2003).  
Apart from its role as a transport protein, additional transthyretin functions have been 
suggested. One lab proposed a protease activity (Liz et al., 2004) that seems important for the 
role of transthyretin as an enhancer of nerve regeneration (Fleming et al., 2007; Liz et al., 
2009). Furthermore, in mice with a compromised heat-shock response (due to heterozygosity 
of the heat-shock transcription factor HSF1) TTR seems to contribute to control neuronal cell 
death and inflammation (Santos et al., 2010). In line with this, transthyretin seems to behave 
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as a neuronal stress protein regulated by HSF1 in human neuroblastoma cells and in an 
Alzheimer’s disease mouse model (Wang et al., 2014). Finally, transthyretin may promote 
increase of glucose-induced cytoplasmic Ca2+ levels and insulin release in pancreatic β-cells 
(Refai et al., 2005).  
 
Figure 18: Model of TTR-52/CED-7 phosphatidylserine vesicle 
transfer – from (Mapes et al., 2012). 
The ATP binding cassette (ABC) transporter CED-7 mediates the 
exposure of phosphatidylserine (PS) on the surface of apoptotic 
cells which is bound by TTR-52. Both CED-7 and TTR-52 promote 
the generation of extracellular PS vesicles between apoptotic and 
engulfing cell. CED-7, TTR-52 and the TTR-52-binding phagocyte 
receptor CED-1 are necessary for the appearance of PS on the 
engulfing cell.  
 
The C. elegans family of TransThyretin-Related genes consists of 59 members but only ttr-52 
has been characterised so far. TTR-52 is secreted and acts as a bridge between 
phosphatidylserine (PS) that is exposed on the surface of apoptotic cells and the phagocyte 
receptor CED-1/MEGF10 (Wang et al., 2010) (Figure 18, Figure 23A). Intriguingly, PS exposure 
becomes reduced in older or unengulfed apoptotic cells and is also detected on the surface of 
phagocytes (Mapes et al., 2012). It was proposed that TTR-52, CED-7 and NRF-5 (Nose 
Resistant to Fluoxetine) promote efflux of PS from apoptotic cells by generation of 
extracellular PS vesicles, thus leading to PS expression on phagocytes in the course of cell 
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corpse clearance (Mapes et al., 2012; Zhang et al., 2012)(Figure 18). TTR-52 is the first example 
of a molecule connecting an ‘eat-me’ signal on apoptotic cells to the CED-1 phagocyte receptor 
in C. elegans; however, TTR-52 is not known to have a role in the recognition of necrotic cells.  
Surprisingly, it was found that ttr-52 and other members of the engulfment pathway are also 
needed for regenerative axonal fusion (Neumann et al., 2014). To mediate the reconnection of 
two axon parts which have been cut by a laser, ttr-52 acts together with the PS receptor psr-1 
upstream of the fusion facilitator eff-1 (epithelial fusion failure) (Neumann et al., 2014). Hence, 
the same genes which mediate recognition and engulfment of apoptotic cells also mediate 
‘stitching’ of neurons. It is not clear however how the decision between removal and 
regeneration is made.  
5.2 Cell death and engulfment 
Apoptosis, necrosis and autophagy are the three main morphologically distinct types of cell 
death. When cells undergo apoptosis, they shrink and when they undergo necrosis, they swell 
(Figure 19) (Kroemer et al., 2009). Cells that die via autophagy have little or no association with 
engulfing phagocytes (Kroemer et al., 2009) and exhibit extensive vacuolisation 
(Nikoletopoulou and Tavernarakis, 2014). However, it is not always possible to determine the 
type of cell death unequivocally, as some cell death markers might not be present and others 
might be shared between the different kinds of death (Syntichaki and Tavernarakis, 2002). 
Also, the same cell can undergo different types of cell death in response to different stimuli 
(Nikoletopoulou et al., 2013). The use of C. elegans as a model organism allowed to decipher 
molecular mechanisms of cell death and engulfment (Hall et al., 1997; Hengartner, 1997). 
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Figure 19: Morphological features of apoptotic and necrotic cells – adapted from (Syntichaki 
and Tavernarakis, 2002; Ziegler, 2004). 
A)-C) Differential interference contrast images of C. elegans cells – adapted from (Syntichaki 
and Tavernarakis, 2002). 
A) Healthy cells marked with green arrows. 
B) Apoptotic cell with compact, button-like appearance marked with red arrow. 
C) Necrotic cell with swollen, vacuole-like appearance. Swollen nucleus marked with blue 
arrow 
D)-F) Transmission electron microscope images of K562 cells – adapted from (Ziegler, 2004), 
Scale bar A, C = 3 μM, B= 2 μM  
D) Healthy cell with normal morphology.  
E) Apoptotic cell with condensed chromatin (electron dense, black structure along nuclear 
membrane) and fragmentation of the nucleus. Nucleoli marked with arrowheads.  
F) Necrotic cell. 
 
5.2.1 Apoptosis  
Apoptosis is a genetically predetermined (‘programmed’) type of cell death. Apoptosis can be 
triggered extrinsically, by activation of cell surface death receptors, or intrinsically, via the 
mitochondrial signalling pathway (Kroemer et al., 2007). The most prominent morphological 
features of apoptotic cells include shrinkage and rounding-up, chromatin and nuclear 
fragmentation and condensation, plasma membrane blebbing, and little or no modification of 
cytoplasmic organelles (Kroemer et al., 2009) (Figure 19B, E). In C. elegans, apoptosis is driven 
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by the core apoptotic pathway consisting of the cell death abnormality genes ced-9/Bcl-2, ced-
4/Apaf-1 and the caspase ced-3 (Wang and Yang, 2016) (Figure 23A). 
Apoptosis occurs in somatic and germline cells during development (Lettre and Hengartner, 
2006) and is assumed to enhance the fitness of the whole organism (Aballay and Ausubel, 
2001). Germ cell-specific apoptosis likely preserves the functionality of oogenesis and can be 
caused by different types of environmental stress (Gartner et al., 2008). DNA damage for 
example induces germ cell apoptosis via the p53 orthologue CEP-1 (C. elegans P-53-like 
protein), which activates the core apoptosis machinery via two BH3- only proteins, EGL-1 (Egg 
laying defective) and CED-13 (Derry et al., 2001; Gartner et al., 2000; Schumacher et al., 2001, 
2005) (Figure 23A). Other types of environmental stress can induce germ cell apoptosis 
independently of egl-1 and cep-1, but mostly dependent on p38 and JNK stress-activated MAP 
kinase pathways (Aballay and Ausubel, 2001; Aballay et al., 2003; Salinas et al., 2006).  
5.2.2 Necrosis  
Classically, necrosis was defined as the type of cell death lacking features of apoptosis or 
autophagy. However, research suggests that the occurrence and course of necrosis can be 
tightly regulated by a conserved set of mechanisms (Galluzzi et al., 2014; Vlachos and 
Tavernarakis, 2010). These mechanisms seem to be largely distinct from apoptosis, since 
necrotic-like deaths are not affected by mutations in the apoptotic core machinery (Reddien 
and Horvitz, 2004) and do not involve caspases (cysteine proteases) (Galluzzi et al., 2014). 
There are a few necrotic-like cell deaths during C. elegans development (Nikoletopoulou and 
Tavernarakis, 2014) but most of the known necrotic cell deaths are based on extrinsic 
induction. Non-developmental necrotic cell death can be evoked by extreme environmental 
conditions – such as heat, hypoxia or hypo-osmotic shock – or by genetically encoded insults 
(Nikoletopoulou and Tavernarakis, 2014). Morphological features of necrosis are the distortion 
of the nucleus and the cell body, swelling of cells and organelles and the infolding and 
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internalisation of plasma membrane (Nikoletopoulou and Tavernarakis, 2014) (Figure 19C, F). 
In addition, increasingly translucent cytoplasm, and plasma membrane rupture with 
subsequent loss of intracellular contents have been suggested as features of necrotic cells 
(Nikoletopoulou and Tavernarakis, 2014). Morphological and mechanistic key features 
between necrotic cell death triggered by hyperactive ion channels in C. elegans and 
‘excitotoxic’ cell death induced by hyperexcitation of postsynaptic cells in higher organisms are 
conserved (Nikoletopoulou and Tavernarakis, 2014).  
In C. elegans, necrosis can be triggered by intracellular ionic imbalance – e.g. as a result of ion 
channel, neurotransmitter receptor or neurotransmitter transporter mutations (Vlachos and 
Tavernarakis, 2010). This imbalance results in Ca2+ dyshomeostasis, which is a key feature for 
necrosis in C. elegans (Xu et al., 2001) and neurodegeneration in higher organisms (Wojda et 
al., 2008). Cytosolic Ca2+ levels can rise via cellular influx or by release from the ER, the main 
intracellular calcium storage compartment (Nikoletopoulou and Tavernarakis, 2014). Ca2+ 
release from the ER is likely mediated by the calreticulin crt-1 (Xu et al., 2001). Excessive 
cytoplasmic Ca2+ causes activation of Ca2+-dependent calpain proteases (such as clp-1 and tra-
3) and lysosomal rupture, which in turn lead to the release of lysosomal cathepsin proteases 
(aspartyl proteases such as asp-3 and asp-4) and the acidification of the cytoplasm (Artal-Sanz 
et al., 2006; Syntichaki et al., 2002, 2005) (Figure 23A). This ‘calpain-cathepsin necrosis 
cascade’ (Figure 20) also exists in primates (Yamashima, 2000). Autophagy, the degradation 
and recycling of cellular components, seems to synergise with lysosomal proteolytic 
mechanisms and endocytosis to mediate necrotic cell death (Samara et al., 2008; Troulinaki 
and Tavernarakis, 2011).  
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Figure 20: The proposed calpain-cathepsin necrosis cascade – from 
(Syntichaki and Tavernarakis, 2002). 
Necrosis can be triggered in many different ways, e.g. by hyperactive ion 
channels and Gαs proteins, and by protein aggregates. This leads to the 
increase in the intracellular cytoplasmic calcium concentration ([Ca++]i). 
Calcium can be mobilised from the endoplasmic reticulum store and/or 
through uptake from the extracellular space and can in turn activate Ca2+-
sensitive calpains, which provoke the release of lysosomal cathepsin 
proteases. This could ultimately lead to cell death.  
 
5.2.3 Phagocytosis 
The removal of dead cells by phagocytosis is important for tissue remodelling and the 
regulation of immune responses (Reddien and Horvitz, 2004). Active phagocytic cells in the 
brain are observed in almost all neurological diseases (Fu et al., 2014), as well as in 6-OHDA 
models of Parkinson’s disease (Long-Smith et al., 2009). In contrast to mammals, there are no 
specialised phagocytes in C. elegans, but cells surrounding dying cells take on that role 
(Reddien and Horvitz, 2004). Furthermore, apoptotic and necrotic cells seem to be engulfed via 
distinct mechanisms in mouse cell culture (Krysko et al., 2006), however in C. elegans, all dead 
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cells seem to be eliminated by the same engulfment pathway (Chung et al., 2000; Li et al., 
2015).  
The recognition of the conserved ‘eat-me’ signal phosphatidylserine (PS) on the surface of 
apoptotic and necrotic cells triggers two partially redundant pathways in the engulfing cell 
(Conradt et al., 2016). In one pathway, the PS receptor psr-1/PSR or the integrin α ina-1 signal 
to ced-2/CRKII, ced-5/DOCK180 and ced-12/ELMO, which in turn control the activation of the 
small GTPase ced-10/Rac1 (Conradt et al., 2016). ced-10 activation leads to the reorganisation 
of the cytoskeleton needed for phagocytosis (Conradt et al., 2016). Apart from PSR-1 and INA-
1, the C. elegans Frizzled homologue MOM-5 (more of MS) can also act as a receptor (Conradt 
et al., 2016). In the second pathway, PS is recognised by the two secreted proteins TTR-52 and 
NRF-5, and CED-7, CED-1/MEGF10 and CED-6 transduce the signal to also activate CED-10 
(Conradt et al., 2016) (Figure 23A). In addition to the relay via TTR-52, CED-1 may also bind 
directly to PS (Li et al., 2015). Similarly, there are several known phagocytic receptors in 
mammals, some of which bind to PS or other ‘eat-me’ signals directly, whereas others 
recognise PS via extracellular, soluble bridging molecules (Ravichandran, 2011). 
PS needs to be translocated from the inner to the outer leaflet of the plasma membrane to act 
as an ‘eat-me’ signal on the cell surface (Eroglu and Derry, 2016). In C. elegans apoptotic cells, 
there are several known mechanisms regulating extracellular phosphatidylserine (PS) 
exposure. Firstly, the aminophospholipid translocase TAT-1 (transbilayer amphipath 
transporters (subfamily IV P-type ATPase)) maintains plasma membrane asymmetry of PS 
(Darland-Ransom et al., 2008; Zullig et al., 2007): tat-1 knockdown was reported to lead to 
abnormal PS exposure, triggering stochastic removal of living cells (Darland-Ransom et al., 
2008) and to prevent PS exposure on apoptotic cells (Zullig et al., 2007). Secondly, it was 
proposed that the phospholipid scramblase SCRM-1 translocates PS from the inner to the 
outer leaflet of the plasma membrane after being activated by mitochondrial release of the 
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worm apoptosis-inducing (AIF) factor homologue WAH-1 (Wang et al., 2007). Thirdly, CED-
8/Xkr8 is activated by caspase cleavage and mediates PS exposure during apoptosis (Chen et 
al., 2013; Suzuki et al., 2013). In summary, TAT-1, SCRM-1 and CED-8 have been shown control 
PS exposure on apoptotic cells.  
Recently, several mechanisms regulating the exposure of PS on necrotic cells in C. elegans have 
been uncovered as well (Li and Zhou, 2015). Ca2+ influx – a key necrosis event – activates the 
neuronal PS-scramblase and TMEM16F homologue anoh-1 (anoctamin (calcium-activated 
chloride channel) homolog), which mediates cell surface exposure of PS (Li et al., 2015). In 
addition, ced-7 also promotes PS exposure and removal of necrotic cells, most likely acting in a 
partially redundant pathway with anoh-1 (Li et al., 2015). Lastly, ced-8 has a modest role in the 
removal of necrotic cells and was also proposed to act in a partially redundant manner with 
anoh-1 (Li et al., 2015). Remarkably, ced-7 and ced-8 have established roles in the removal of 
apoptotic cells, but anoh-1 function seems to be specific for necrotic cells. Thus, there is likely 
a set of shared and specific mechanisms regulating PS exposure of apoptotic and necrotic cells.  
Besides PS, the calcium-sensing chaperone calreticulin has been reported to act as a second 
general recognition ligand for engulfment receptors in human cell lines (Gardai et al., 2005). 
Remarkably, calreticulin only drives engulfment of apoptotic cells once ‘don’t eat me’ signals 
are inactivated (Gardai et al., 2005). Indeed, various types of ‘eat-me’ and ‘don’t eat me’ 
signals have been proposed to provide a combinatorial code for phagocytes (Zitvogel et al., 
2010). It is conceivable that these codes could vary between different cell types and in 
response to different stimuli. 
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6 RESULTS TTR-33 
6.1 ttr-33 encodes a transthyretin-related gene 
To determine why the isolated G27E or the L72F substitution in TTR-33 (TransThyretin-Related 
family domain) render C. elegans dopaminergic neurons susceptible to 6-OHDA, we first 
turned towards protein alignment and structural modelling methods. TTR-33, like the majority 
C. elegans transthyretin-related proteins (Wang et al., 2010), is predicted to be a secreted, 
non-cytoplasmic protein (Figure 21A). The putative N-terminal signal peptide part of TTR-33 
seems to fold into a helix, whereas the rest of the protein consists of beta sheets (Figure 21b). 
 
 
Figure 21: TTR-33 signal peptide prediction. 
A) TTR-33 signal peptide (in red), transmembrane domain (in grey) and cytoplasmic/non-
cytoplasmic part (in green and blue, respectively) prediction by Phobius 
(http://phobius.sbc.su.se/).  
B) TTR-33 secondary structure prediction indicating helices (red tubes) and beta strands (green 
arrows) with JPred4  
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Figure 22: gt1983 leads to a glycine to glutamate conversion (G27E) in the transthyretin-
related protein TTR-33. 
A) Alignment of all C. elegans TTR’s with TTR-33 (last row). The corresponding amino acids of 
the mutations in TTR-33 (G27 and L72) are highlighted in red and cysteines marked in yellow. 
The conservation score, quality and consensus of the alignment are each shown as a bar graph 
in the bottom of the alignment.  
B) Predicted protein structure model of TTR-33 created with homology modelling based on the 
structure of TTR-52 (PDB ID: 3UAF). Mutated residues are indicated in red and conserved 
cysteines in yellow. 
C) Predicted TTR-33 structure (grey with indicated mutated sites in red and cysteine bridges in 
yellow) with overlaid TTR-52 structure (black with indicated sm211 mutation site in pink and 
cysteine bridges in orange). TTR-52 residues for which mutation leads to loss of dimerisation 
are marked in blue. Note that the TTR-52 α-helix which does not occur in TTR-33 is assumed to 
be an artefact due to mutations that were required for crystallisation (Kang et al., 2012). 
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Amino acids that are important for the protein family function are expected to be conserved 
and we found that this is the case for L72 but not G27 of TTR-33 when aligning C. elegans (in 
red in Figure 22A). However, both residues were part of two neighbouring beta strands in the 
predicted TTR-33 3D protein structure (in red in Figure 22B). Since these beta strands form 
part of the dimer interface of the only other characterised C. elegans transthyretin-related 
protein, TTR-52 (Kang et al., 2012) (residues that interrupt the dimer interface in blue in Figure 
22C), it is possible that the substitutions G27E and L72F interrupt dimerisation of TTR-33. In 
addition, we found conservation of 3 cysteine residues (in yellow in Figure 22A, B) that could 
potentially act as sensors or scavengers of reactive oxygen species.  
TTR-33 is predicted to exhibit high structural similarity to the only characterised C. elegans 
transthyretin-related protein TTR-52 (Figure 22C), which bridges apoptotic cells to the 
engulfment machinery (Kang et al., 2012; Wang et al., 2010). Therefore, we aimed to 
investigate if phagocytosis could be involved in the mechanism causing premature 
dopaminergic neurodegeneration in ttr-33(gt1983).  
6.2 Dopaminergic neurons are engulfed but do not undergo apoptosis upon 
intoxication with 6-OHDA 
TTR-52 is the only characterised C. elegans transthyretin-related protein and was reported to 
bind to phosphatidylserine on the surface of apoptotic cells and to the phagocyte receptor 
CED-1/MEGF10 (Wang et al., 2010). It is not known how C. elegans dopaminergic die upon 
exposure to 6-OHDA, so we wanted to address if they might be engulfed. The two branches of 
the C. elegans engulfment pathway merge on ced-10 (Figure 23A) and the ttr-52/ced-1/ced-6 
branch is also required for axon regeneration (Neumann et al., 2014). We found that 
neurodegeneration in the ttr-33 mutant is slightly suppressed by mutation of ced-2, which is 
part of the ced-2/ced-5/ced-12 branch, and highly suppressed by ced-6, which is part of the ttr-
52/ced-1/ced-6 branch (Figure 23B). Dopaminergic cell loss in the ttr-33 mutants is largely 
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prevented when mutating the end point of the pathway, ced-10, so the two branches might 
act additively (Figure 23B). Importantly, a loss-of-function mutation in ttr-52 did not confer 
hypersensitivity to dopaminergic neurons and did not influence the phenotype of ttr-33 
(Figure 23B). Therefore, in contrast to TTR-33, TTR-52 does not seem to have a role in 6-OHDA-
induced neurodegeneration. To exclude that dopaminergic neurons are only engulfed in the 
ttr-33 mutant background, we confirmed that mutations in ced-6 or ced-10 also alleviate 
dopaminergic neurodegeneration in a wild-type background (Figure 23C). We conclude that 
the 6-OHDA-induced dopaminergic cell death is alleviated by mutation of the phagocytosis 
genes ced-6 and ced-10.  
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Figure 23: Dopaminergic neurons are engulfed but do not undergo apoptosis after 6-OHDA 
intoxication. 
A) Cartoon of apoptotic and necrotic-like cell death pathway and subsequent engulfment. 
Marked in yellow are the genes that were tested in this study. 
B-D) Dopaminergic neurons were scored 72 h after intoxication with indicated concentration of 
6-OHDA.  
B) Effect of mutations in engulfment pathway and ttr-52 in the ttr-33 mutant background. Error 
bars = SEM of 2 biological replicates, each with at least 50 animals per strain and concentration. 
Total number of animals per condition n = 200-240 (****p<0.0001, n.s. p>0.05; G-Test 
comparing ttr-33 mutant data to double mutant data), except for ced-10;ttr-33 10 mM with n = 
70.  
C) Effect of mutations in engulfment pathway on neurodegeneration in a wild-type (wt) 
background. Error bars = SEM of 2 biological replicates, each with at least 50 animals per strain 
and concentration. Total number of animals per condition n = 120-220 (****p<0.0001, 
**p<0.01, *p<0.05, n.s. p>0.05; G-Test), except for ced-10 50 mM which was tested once with n 
= 35.  
D) Effect of mutations in calcium regulator calreticulin crt-1 on neurodegeneration in a wild-
type background. Error bars = SEM of at least 3 biological replicates with at least 90 animals per 
strain. Total number of animals per strain = 200-310 (** p<0.02; G-Test).  
 
Before cells are engulfed, they commonly undergo apoptosis or a necrosis-type cell death 
(Figure 23A). To determine if any of these two cell death types occur during dopaminergic 
neurodegeneration, we first tested the caspases ced-3 and ced-4, which are part of the 
canonical apoptosis pathway. In line with previous reports (Nass et al., 2002), we found that 
blocking the apoptosis pathway did not prevent dopaminergic cell death (Figure 24A, B). On 
the contrary, ced-3 and ced-4 seem to have a protective role as their mutation led to increased 
neurodegeneration (Figure 24A, B). In line with this, it has been reported that the apoptosis 
pathway can act protectively after sensing of mitochondrial reactive oxygen species (mtROS) 
(Yee et al., 2014). ced-13 also influences the mtROS sensing pathway and we found that 
mutation of ced-13 conferred slight hypersensitivity to dopaminergic neurons after 
intoxication with 10 mM 6-OHDA (Figure 24B). Since mutations in the apoptosis/mtROS-
sensing pathway only conferred minor sensitivity to 6-OHDA, it is difficult to tell if there are 
additive effects in the glit-1 mutant background (Figure 24B). However, a mutation in ced-4 did 
not increase, but rather decrease neurodegeneration in the ttr-33 mutant (Figure 24A). In 
summary, mutating the apoptosis genes ced-3 and ced-4 did not prevent 6-OHDA-induced 
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dopaminergic cell death, but instead increased neurodegeneration. We speculate that ced-3 
and ced-4 might have a protective role based on their function as mtROS sensors. 
Since dopaminergic neurons do not seem to die an apoptotic cell death, we aimed to 
determine if they die via necrosis. For this, we tested a strain with a mutation in the 
calreticulin crt-1, a Ca2+-binding and Ca2+-storing chaperone in the ER which mediates calcium 
release that is necessary for necrosis (Xu et al., 2001). A mutation in crt-1 mutation led to a 
minor increase in dopaminergic neuron loss in wild-type (Figure 23D), however the crt-1;glit-1 
double mutant appeared synthetic lethal (data not shown): We used a fluorescently labelled 
balancer chromosome to keep crt-1 in a heterozygous state in a glit-1 homozygous 
background. In the next generation, genetic segregation of the crt-1 and the balancer 
chromosome is expected. However, we did not find any non-fluorescent animals, indicating 
that crt-1 homozygosity is lethal in the glit-1 homozygous background. In summary, it is 
possible that 6-OHDA triggers a necrosis-like cell death of dopaminergic neurons. 
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Figure 24: Dopaminergic neurons are engulfed but do not undergo apoptosis after 6-OHDA 
intoxication. 
Dopaminergic neurons were scored 72 h after intoxication with indicated concentration of 6-
OHDA.  
A) Effect of apoptosis/mtROS pathway mutation on ttr-33 neurodegeneration. Error bars = 
SEM of 3 biological replicates, each with at least 100 animals per strain and concentration. 
Total number of animals per condition n = 300-330 (****p<0.0001, *p<0.05, n.s. p>0.05; G-
Test). 
B) Effect of apoptosis/mtROS pathway mutations on glit-1 neurodegeneration. Error bars = 
SEM of at least 3 biological replicates, each with at least 50 animals per strain and 
concentration. Total number of animals per condition n = 150-530 (****p<0.0001, **p<0.01, 
n.s. p>0.05; G-Test). 
 
6.3 ttr-33 is expressed in the posterior arcade cells 
TTR-33 is predicted to be a secreted protein, so a transcriptional reporter might be needed to 
identify the location of protein production, and a translational reporter to identify its site of 
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action. We find that in five independent lines, an extrachromosomal transcriptional Pttr-
33::gfp constructs exclusively labelled six cells in the head of L1 larvae, the stage most sensitive 
to 6-OHDA. Two cells were located next to the first pharyngeal bulb and four were situated 
halfway between mouth and first pharyngeal bulb and form protrusions towards the mouth of 
the larva (Figure 25A, B). The cells could already be detected as early as the embryonic pretzel 
stage (Figure 25C). Comparison with the cell atlas of C. elegans (www.wormatlas.org) revealed 
that these six cells are most likely the posterior arcade cells, which link the external epidermis 
and anterior pharynx/foregut (Portereiko and Mango, 2001). There is a specific promoter for 
these cells (Pbath-15) which will be used to express TTR-33 only in the posterior arcade cells 
for tissue-specific rescue. A translational Pttr-33::ttr-33::gfp construct in contrast only weakly 
labelled several cells in the head (Figure 25D). By using different fluorophores, it will be 
addressed if the cells labelled by the transcriptional and translational reporter construct are 
identical − or if TTR-33 is secreted from the posterior arcade cells and then localises to other 
cells.  
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Figure 25: ttr-33 is expressed in arcade cells. 
A) Transcriptional reporter ExPttr-33::gfp in L1 stage larva. 
B) Magnified view of transcriptional reporter ExPttr-33::gfp in L1 stage 
larva in A). 
C) Transcriptional reporter ExPttr-33::gfp in pretzel stage embryo, 
speckled signal is autofluorescence from the intestine. 
D) Translational reporter Pttr-33::ttr-33::gfp in L1 stage larva. 
 
  
L1 stage larvaA Head L1 stage larvaB
Embryo pretzel stageC Head L1 stage larvaD
ExPttr-33::gfp ExPttr-33::gfp
ExPttr-33::gfp Pttr-33::t r-33::gfp
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7 DISCUSSION HYPERSENSITIVE MUTANTS 
7.1 Oxidative stress sensitivity 
We screened for genes that protect from 6-hydroxydopamine (6-OHDA)-induced dopaminergic 
neurodegeneration and isolated and mapped a mutation in the neuroligin-like gene glit-1 and 
the transthyretin-like gene ttr-33. The tetraspanin tsp-17 is sensitive to 6-OHDA as well and 
was characterised in a previous study (Masoudi et al., 2014). We could show that glit-1, ttr-33 
and tsp-17 also exhibit reduced survival − but no dopaminergic neurodegeneration − after 
exposure to paraquat, another oxidative-stress inducing drug. To our knowledge, there is only 
one study that reported paraquat-induced loss of dopaminergic dendrites (González-Hunt et 
al., 2014), however worms were chronically exposed for 48 h without food, so additive effects 
conferred by starvation are possible. Even though both drugs are thought to act by inducing 
oxidative stress, it is likely that 6-OHDA – because of its specific uptake into dopaminergic 
neurons – leads to a higher intracellular concentration of damaging ROS than paraquat, and 
therefore dopaminergic neuron loss might occur well before the lethality threshold is reached.  
The hypersensitivity to 6-OHDA and paraquat in L1 stage larvae might be caused by a reduced 
capacity to respond to oxidative stress, since preliminary experiments showed diminished 
Pgst-4::gfp oxidative stress reporter expression in glit-1 L4 stage mutants. This result will be 
followed up by measuring stress reporter fluorescence after oxidative stress induction in wild-
type and mutant animals at different life cycle stages. As a complementary approach, we will 
determine transcription of the oxidative stress reporter by RT PCR. It is also possible to 
measure reactive oxygen species (ROS) more directly e.g. by staining C. elegans with 
Mitotracker Red (Schmeisser et al., 2013a), and to measure the effects of ROS on the worms 
e.g. by determining protein carbonylation (Hunter et al., 2010). In addition, we will also test if 
expression of ttr-33 – and glit-1 and tsp-17 – is transcriptionally induced in response to 
oxidative stress. Finally, we aimed to determine if known stress response pathways confer 
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resistance to 6-OHDA in a similar manner as glit-1, ttr-33 and tsp-17. Surprisingly, the oxidative 
stress ‘master regulator’ skn-1 does not seem to mediate the response to 6-OHDA, since skn-1 
mutant worms are not sensitive to the drug. However, we note that hyperactivation of skn-1 
had a protective effect in wild-type and mutant worms alike. Therefore, glit-1, ttr-33 and tsp-
17 are likely part of other another defence system that protects dopaminergic neurons from 
the effects of 6-OHDA.  
7.2 ER stress resistance and unfolded protein response signalling 
While being sensitive to oxidative stress, glit-1, ttr-33 and tsp-17 L1 stage mutants are resistant 
to protein folding stress. Remarkably, worms carrying a mutation in the Parkinson’s disease 
gene pink-1 were reported to share these phenotypes (Sämann et al., 2009), but they are not 
sensitive to 6-OHDA (our data). As preliminary results with glit-1 L4 stage mutants suggest, the 
resistance to endoplasmic reticulum (ER) stress might be explained by an upregulation of the 
ER unfolded protein response (UPR) at basal conditions. These data need to be followed up by 
measuring Phsp-4::gfp UPR ER reporter levels after induction of ER stress in wild-type and 
mutant worms at different life cycle stages. In addition, transcription levels of the ER UPR 
reporter gene will be determined with and without induction in wild-type and mutant animals. 
The UPR has two phases, a first phase for cellular protection and, if the cell cannot be saved, a 
second phase to trigger cell death (Urra et al., 2013). The primary phase of the UPR comprises 
a reduction of protein synthesis and indeed – as expected for worms with lower protein 
synthesis levels − glit-1, ttr-33 and tsp-17 are sensitive to the translation inhibitor hygromycin. 
However, a study reported the induction of oxidative stress by hygromycin (Oung et al., 2015), 
so the mutants’ susceptibility to hygromycin might reflect another form of oxidative stress 
sensitivity rather than a reaction to protein synthesis inhibition. If protein translation were 
indeed diminished in the mutants, they would be expected to grow slower and we found that 
glit-1 mutants show a clear and ttr-33 mutants a minor growth delay (Figure 3C). We can now 
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determine if the glit-1 growth delay is bypassed by mutation of the UPR gene ire-1 in the glit-
1;ire-1 double mutant. We note that the strongly inhibited growth of the glit-1(ok237) deletion 
mutant is likely due to the fact that ok237 deletion also compromises the promoter of the 
large ribosomal subunit protein rpl-25.1. In summary, we have indications that the ER UPR is 
upregulated in in glit-1, ttr-33 and tsp-17 mutants at basal conditions. Upregulation of the UPR 
is likely associated with increased cellular stress, therefore it is possible that upon additional 
challenge with 6-OHDA, dopaminergic neuron death is triggered more readily. In line with this 
argument, we find a reduction in 6-OHDA-induced dopaminergic neurodegeneration when we 
mutate the ER UPR gene ire-1 in ttr-33 mutants – as well as a weaker effect in glit-1 mutants.  
7.3 Genetic interaction with MAPK stress response pathways 
To test if known C. elegans stress response pathways are involved in the protection against 6-
OHDA, we included p38 and JNK MAPK (c-Jun N-terminal kinase mitogen-activated protein 
kinase) mutants in the 6-OHDA assay. We found that the MAPK mutations did not lead to 
premature dopaminergic neurodegeneration as a mutation in glit-1, ttr-33 or tsp-17 and did 
not influence the extent of neuronal loss in glit-1 mutants. However, the JNK orthologue jnk-1 
aggravates 6-OHDA-induced neurodegeneration in the ttr-33 mutant. The seemingly specific 
effect of the jnk-1 mutation on ttr-33 mutants needs to be confirmed by testing the influence 
of the jnk-1 mutation on degeneration in wild-type animals at higher concentrations of 6-
OHDA. However, the protective function of jnk-1 in the 6-OHDA assay is in agreement with 
literature showing its function in the resistance against oxidative stress (Neumann-haefelin et 
al., 2008; Oh et al., 2005).  
There is a second JNK (c-Jun N-terminal kinase) family member in C. elegans, kgb-1, but we 
were not able to create a double mutant between ttr-33 and kgb-1. We used a balancer 
chromosome to keep ttr-33 in a heterozygous state in a kgb-1 homozygous background. In the 
next generation, we did not find any animals that did not carry the balancer. KGB-1 is required 
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for resistance to the ER toxin tunicamycin (Mizuno et al., 2008) and was proposed to regulate 
several transthyretin-related genes (Twumasi-Boateng, 2012), so it is conceivable that kgb-1 
acts upstream of ttr-33. However, the kgb-1 mutant on its own does not show enhanced 6-
OHDA-induced neuronal loss as ttr-33, so if kgb-1 is involved in the protection against 6-OHDA, 
its function must be redundant. The influence of kgb-1 on dopaminergic degeneration in an 
otherwise wild-type background has to be tested still upon treatment with higher 
concentrations of 6-OHDA. We note however that it is likely that KGB-1 has an important role 
in organismal protection since the protein was reported to transmit a neuroendocrine signal 
upon disruptions in core cellular processes – including translation, respiration and protein 
turnover (Melo and Ruvkun, 2012). In summary, the JNK protein JNK-1 provides protection 
against 6-OHDA-induced neurodegeneration in ttr-33 mutants and KGB-1 might genetically 
interact with ttr-33.  
7.4 Transthyretins might be secreted to support organismal defence 
TTR-33 might be part of an endocrine defence pathway. The nematode-specific transthyretin-
related protein family is expanded and comprises 59 members, 54 of which are predicted to be 
secreted (Petersen et al., 2011; Wang et al., 2010). Several studies indicate that transthyretin-
related genes might be induced in response to environmental challenges such as oxidative 
stress or pathogen exposure: Expression of ttr-33 and other transthyretin-related genes is 
upregulated upon loss of wdr-23 in neurons – leading to a dis-inhibited skn-1 oxidative stress 
response (Staab et al., 2014). Furthermore, oxidative stress induced by tert-butyl hydrogen 
leads to upregulation of several transthyretin-related genes in a skn-1-independent manner 
(Oliveira et al., 2009) and treatment with the mitochondrial complex I inhibitor rotenone leads 
to upregulation of 42 of 59 transthyretin-related genes (Schmeisser et al., 2013b). In line with a 
putative role as an oxidative stress defence protein, TTR-33 possesses conserved cysteine 
bridges with which it could sense or scavenge ROS – similar to the antioxidant glutathione. In 
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addition, bacterial infection was reported to cause upregulation of ttr-33 (Engelmann et al., 
2011) and several other transthyretin-related proteins (Treitz et al., 2015). In line with a 
possible role in the C. elegans innate immune response, ttr-33 gene expression correlates with 
genes that are associated with the gene ontology terms ‘defence response to fungus’, 
‘negative regulation of metalloenzyme activity’ and ‘neuropeptide signalling pathway’. In 
summary, the transthyretin-related protein family seems to be part of a hormone-like 
organismal defence.  
7.5 Starvation protects against 6-OHDA toxicity and might induce expression of 
glit-1 and ttr-33 
C. elegans triggers diverse signalling pathways to survive periods of starvation (Larance et al., 
2015). Intriguingly, dietary restriction protects against 6-OHDA-induced neurodegeneration 
(González-Hunt et al., 2014; Jadiya et al., 2011) and might lead to upregulation of glit-1 and ttr-
33 transcripts: Fasting significantly induces gene expression of glit-1 and several transthyretin-
related genes (Uno et al., 2013), and protein levels of the same and additional transthyretin-
related genes (Larance, Pourkarimi et al., 2015). Furthermore, according to expression data 
from modENCODE libraries (linked to wormbase), ttr-33 expression is predicted to be highest 
in dauer stage, a larval stage that is entered upon nutrient deprivation (Hu, 2007). We still 
need to test this prediction with our ttr-33 transcriptional reporter. Since starvation leads to a 
decrease in 6-OHDA-induced neurodegeneration, the time L1 stage larvae were incubated in 
liquid without food before 6-OHDA intoxication was kept the same for all experiments. 
However, sometimes filtering of L1 stages from unstarved plates was necessary due to the 
swimming defect of two strains (tsp-17(tm4995) and skn-1(zu67)/nT1). We confirmed that 
starvation leads to partial resistance to 6-OHDA-induced degeneration: 60% of glit-1 mutants 
exhibited degeneration of all dopaminergic head neurons 72 h after intoxication with 0.75 mM 
6-OHDA if worms were filtered from an unstarved plate (Figure 10A), but only 10% if the 
mutants were incubated without food (Figure 14C). In summary, glit-1, ttr-33 and other 
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transthyretin-related genes might be induced in unfavourable environmental conditions 
including food deprivation.  
7.6 Lifespan reduction and a possible connection to the insulin/insulin-like 
signalling pathway 
Loss of genes that are important for environmental stress protection is expected to cause 
reduced organismal fitness and indeed, ttr-33 mutants – as well as glit-1 and tsp-17 mutants – 
die earlier than wild-type animals. Other transthyretin-related genes could have a role in 
lifespan regulation as well: Expression of almost half of all transthyretin-related genes was 
found to be significantly higher in the long-lived insulin-like growth factor orthologue daf-2 
(abnormal dauer function) mutant (Halaschek-wiener et al., 2005; Rizki et al., 2011), similar to 
heat-shock proteins and neuropeptide-like genes (Halaschek-wiener et al., 2005). In contrast, 
very few transthyretin-related gene are downregulated in the daf-2 mutants, including ttr-1 
(Rizki et al., 2011), and ttr-1 RNAi knockdown was indeed found to extend lifespan in an 
independent study (Hansen et al., 2005).  
The insulin/insulin-like growth factor signalling pathway might be involved in the response to 
6-OHDA. DAF-2 is the only C. elegans insulin/insulin-like growth factor I receptor orthologue 
and negatively regulates the sole forkhead box O (FOXO) transcription factor homologue DAF-
16. DAF-16 is a key regulator of C. elegans oxidative stress resistance (Baumeister et al., 2006). 
Recently, ttr-33 appeared among the neuronal targets of the DAF-16-dependent 
insulin/insulin-like growth factor signalling pathway (Kaletsky et al., 2015). It was also shown 
that JNK-1, which provides protection against 6-OHDA in the ttr-33 mutant background, acts 
via DAF-16 to mediate stress resistance (Neumann-haefelin et al., 2008; Oh et al., 2005). 
Finally, even though we found that SKN-1 does not seem to have a major role in the protection 
against 6-OHDA, it was reported that SKN-1 and DAF-16 can act non-redundantly to sustain 
mitochondrial function in response to oxidative stress (Palikaras et al., 2015). In summary, 
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there are strong indications that the DAF-16 insulin/insulin-like signalling pathway could have a 
role in the response to 6-OHDA. We will therefore test if daf-2 and daf-16 mutants show 
decreased and increased 6-OHDA-induced dopaminergic neurodegeneration, respectively. 
However, we note that the two functions – protection against 6-OHDA and protection against 
premature death – are mediated at different life cycle stages and might therefore be 
independent of each other: The sensitivity to 6-OHDA declines latest in L4 stage worms in glit-
1, ttr-33 and tsp-17 mutants, whereas lifespan assays only start at L4 stage.  
7.7 Finding interactors of glit-1  
glit-1 is a neuroligin-like gene, however glit-1 is unlikely to mediate protection against 6-OHDA 
via the common neuroligin partner neurexin. Mutations in the only C. elegans neurexin nrx-1 
do not phenocopy or specifically alter the 6-OHDA sensitivity of glit-1 mutants. However, there 
are a few examples of neuroligin functions exerted in a neurexin-independent manner such as 
increase in synaptic density in cell culture (Ko et al., 2009) and stimulation of insulin secretion 
on the surface of pancreatic beta-cells (Suckow et al., 2012). Like mammalian neuroligins 
(Bemben et al., 2015), GLIT-1 possesses a C-terminal PDZ (PSD95, Dlg1, zo-1) domain-binding 
sequence and we used this feature to predict several alternative GLIT-1 interactors. Some of 
the candidate PDZ proteins were already shown to interact with glit-1 orthologs: The 
mammalian homologue of SHN-1, SHANK3, was shown to bind indirectly to neuroligin and 
SHANK3 mutations are – similar to mutations in neuroligins and neurexins – associated with 
autism (Südhof, 2008). C. elegans SHN-1 exhibits a similar expression pattern as glit-1 in 
pharynx, intestine and neurons (Jee et al., 2004). In addition to SHN-1, DLG-1 appears in the 
list of putative GLIT-1 interactors. The Drosophila homologues of GLIT-1 and DLG-1, Gliotactin 
and Discs Large, were reported to associate in a Ca2+-dependent manner (Padash-Barmchi et 
al., 2013). In addition, Drosophila JNK was shown to act downstream of Gliotactin and Discs 
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Large (Padash-Barmchi et al., 2013). Strong candidates such as shn-1 or dlg-1 can be tested for 
their involvement in glit-1-mediated neuroprotection.  
7.8 glit-1 genetic interaction with dopamine metabolism 
glit-1 might influence dopamine turnover since glit-1 mutants exhibit signs of increased 
dopamine signalling, i.e. a higher degree of paralysis when put on plates with dopamine. To 
exclude that the glit-1 phenotype is based on dopamine-independent effects, we will test the 
glit-1;dop-3 double mutant: As the inhibitory dopamine receptor dop-3 mediates the 
dopamine-induced paralysis (Allen et al., 2011), the glit-1 phenotype should be rescued in the 
in glit-1;dop-3 mutants. Importantly, higher intrinsic dopamine release might explain the 6-
OHDA sensitivity of the glit-1 mutant: Increased release of dopamine is expected to lead to 
increased dopamine uptake. Since dopamine and 6-OHDA enters the neurons in the same way 
via the dopamine transporter, more 6-OHDA might thus enter dopaminergic neurons in the 
glit-1 mutant. In line with this mechanism of action, we find that decreasing the amount of 
dopamine that is competing with 6-OHDA for entry – i.e. by decreasing synthesis or by 
decreasing vesicle packing – worsens the glit-1 neurodegeneration phenotype. We note that 
the dopamine paralysis assay was conducted with L4 stage worms, whereas the 6-OHDA 
intoxication assay is done with L1 stage larvae. In the moment we cannot be sure about the 
site of action of glit-1 in L1 stage worms since the tissue-specific rescue experiments still have 
to be conducted. However, glit-1 might be expressed in dopaminergic neurons mutant in 
adults (Figure 17C, D), and therefore an influence of glit-1 on dopamine signalling is possible. 
Another indication that glit-1 mutants exhibit enhanced dopamine signalling is their decreased 
rate of egg-laying, a behaviour which is inhibited by dopamine (Schafer and Kenyon, 1995). 
However, egg-laying is controlled by many different pathways (Schafer, 2005), thus it is 
possible that egg-laying defects of the glit-1 mutant are not caused by increased dopamine 
signalling. The results from these behavioural assays could be confirmed by measuring 
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dopamine signalling more directly, for example with a dopamine vesicle release assay. In this 
assay, the recovery of GFP-tagged synaptobrevin, a synaptic vesicle marker, is followed after 
photobleaching (Voglis and Tavernarakis, 2008).  
7.9 glit-1 and tsp-17 might act via partially overlapping pathways 
glit-1 and tsp-17 mutants are equally sensitive to 6-OHDA and the glit-1;tsp-17 does not 
exhibit an increased sensitivity compared to the single mutants. Furthermore, both mutants 
show signs of higher dopamine signalling, suggesting that the two genes might act in the same 
pathway. However, in the dopamine paralysis assay the tsp-17;glit-1(gt1981) double shows a 
stronger phenotype than the respective single mutants. In addition, tsp-17 exhibits dopamine 
receptor-dependent swimming-induced paralysis (SWIP), another indication for elevated 
dopamine signalling and a phenotype which is not shared by glit-1 mutants. We think that it is 
possible that, compared to the tsp-17(tm4995) deletion, the glit-1(gt1981) point mutation 
might have a weaker and therefore undetectable effect in the SWIP assay. To determine 
epistatic effects between the tsp-17 and glit-1 deletion alleles, we aimed to generate the tsp-
17(tm4995);glit-1(ok237) double, but it was only possible to get to the 
heterozygous/homozygous stage. Due to the close proximity of tsp-17 and glit-1 (3 cM 
distance) the use of a genetic balancer covering only one of the two genes is not possible. 
Therefore, we conclude that the combination of the glit-1 and tsp-17 deletion alleles might be 
synthetically lethal. In summary, mutation of tsp-17 induces similar but stronger dopamine 
signalling defects than mutation of glit-1, so the genes might act via partially overlapping 
mechanisms.  
7.10 Increased organismal drug uptake unlikely mechanism for glit-1 mutant 
The homologue of glit-1 in Drosophila is involved in the development of the invertebrate tight 
junction equivalent (Genova and Fehon, 2003; Schulte et al., 2003, 2006), so it is possible that 
glit-1 mutants are sensitive to 6-OHDA due to higher epithelial permeability for drugs. In 
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addition, the transcriptional reporter indicates strong glit-1 expression in the pharynx and in 
the intestine, the tissues which probably represent the main routes of 6-OHDA uptake in liquid 
culture. However, glit-1 mutants show resistance to tunicamycin, so they are unlikely to show 
a generally increased organismal drug uptake. Also, glit-1 mutant sensitivity to 6-OHDA is 
abolished by mutation of the dopamine transporter dat-1, so if the drug is prevented from 
entering the neuron it is not having an increased effect in the mutant anymore. Finally, we 
could not detect an effect on the development of glit-1 mutant larvae after intoxication with 6-
OHDA – as it might be expected if a greater amount of the oxidative-stress inducing drug was 
able to cross epithelial barriers. To define the place in which GLIT-1 protects against 6-OHDA, 
tissue-specific rescue experiments will be conducted by expressing GLIT-1 only in pharynx, 
intestine or neurons – particularly dopaminergic neurons. We find that in adult animals, glit-1 
might be expressed in neurons, in line with a study that reported glit-1 neuronal expression in 
adults only (Kaletsky et al., 2015). Since 6-OHDA intoxication is conducted in the L1 larval 
stage, glit-1 possibly exerts its function from non-neuronal tissue. However, even if the main 
function of glit-1 is cell-adhesion, this does not necessarily imply that the mechanism of action 
is increased epithelial permeability. For example, neural cell adhesion molecules (NCAMs) have 
roles in cell-cell adhesion and oxidative stress-induced cleavage of NCAM-180 by the matrix 
metalloprotease MMP-9 was reported to increase neuronal damage in conditions of ischemic 
stress (Fujita-Hamabe and Tokuyama, 2012; Shichi et al., 2011). In summary, it cannot be 
excluded, but it is unlikely that the mechanism of action of glit-1 involves a generally increased 
drug uptake. 
Mutation of glit-1 induces similar phenotypes as mutation in tsp-17, a gene which was shown 
to act in dopaminergic neurons (Masoudi et al., 2014). To determine the site of action of glit-1, 
expression constructs for tissue-specific rescue are required. Unfortunately, C-terminal-tagging 
of GLIT-1 seems to render the protein non-functional even when tagging the endogenous 
locus, as the glit-1 6-OHDA sensitivity is not rescued in a glit-1/GLIT-1::GFP transheterozygote. 
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Tagging in the unstructured and intracellular C-terminal part of GLIT-1 still seems like the best 
option and we will now try to place the GFP behind a linker sequence to avoid interfering with 
PDZ protein binding. In parallel, tissue-specific rescue constructs without fluorophores will be 
created to determine in which tissue glit-1 functions to protect from 6-OHDA toxicity.  
7.11 The mechanism of action of ttr-33 is most likely different from glit-1 and tsp-
17  
In contrast to glit-1 and tsp-17 mutants, the ttr-33 mutant does not show dopaminergic 
signalling defects and is less sensitive to 6-OHDA and paraquat. Due to its different sensitivity 
window in the 6-OHDA assay, it was not possible to determine if ttr-33 could lie in same 
pathway as tsp-17 and glit-1. The ttr-33(gt1983) mutants could simply exhibit a weaker 
phenotype, but it is also possible that the ttr-33 point mutation they carry does not lead to a 
null phenotype. We aim to treat the double mutant strains with RNAi targeting the third gene 
to investigate genetic interactions between ttr-33, glit-1 and tsp-17 again. We note the 
surprising finding that the ttr-33 orthologue transthyretin carries thyroxine, and the precursor 
of thyroxine is one of the proposed glit-1 orthologues thyroglobulin.  
7.12 Evidence for and against a role of TTR-33 in protein folding 
Misfolding and aggregation of transthyretin, the human TTR-33 orthologue, is linked to the 
development of amyloid diseases. We hypothesised that the ttr-33 mutations could facilitate 
TTR-33 aggregation and thus cause increased dopaminergic neurodegeneration. Indeed, 
neurodegeneration in the ttr-33 mutant is reduced in the unfolded protein response loss-of-
function mutant ire-1. This amelioration seems to be specific for the ttr-33 mutant since 
neurodegeneration in the glit-1 mutant is largely unaffected by mutation of ire-1. However, we 
still need to investigate the effects of ire-1 on wild-type dopaminergic neurodegeneration at 
higher concentrations of 6-OHDA. If TTR-33 protein aggregation was causing the 
hypersensitivity of dopaminergic neurons, it might also explain why injection of (an excessive 
88 
 
number of) ttr-33 wildtype copies did not rescue the gt1983 phenotype during the mapping 
procedure (data not shown). However, if mutated TTR-33 is more prone to aggregation than 
wild-type protein, it would be expected that not all TTR-33 copies need to carry a mutation 
before inducing a phenotype, so ttr-33 should exhibit a ‘gain-of-function’, dominant 
phenotype. Yet, since ttr-33(gt1983) behaves in a recessive fashion, the mechanism of action is 
likely based on the loss of gene function. Hence, the physiological role of ttr-33 might provide 
the key to understand its protection against 6-OHDA-induced neurodegeneration.  
7.13 ttr-33 might be involved in the engulfment of dopaminergic neurons 
The only characterised member of the transthyretin-related protein family in C. elegans is ttr-
52. TTR-52 serves as a ‘eat me’-signal for recognition of apoptotic cells (Wang et al., 2010) and 
yet as a ‘save me’-signal to promote regenerative axonal fusion (Neumann et al., 2014). In 
both cases, TTR-52 relays the information to the cell corpse engulfment pathway, yet it is not 
known if any other of the 59 C. elegans transthyretin-related proteins has a similar role. It is 
conceivable that the distinct members of the family of transthyretin-related proteins may 
target distinct cell types or that they may act upon different stimuli. Indeed, transthyretin-
related genes seem to be secreted in different environmental conditions (see above), but in 
contrast to ttr-33 mutants, ttr-52 mutants are not hypersensitive to 6-OHDA. TTR-52 is 
synthesized in and secreted from the intestine and thus labels apoptotic cells far from where it 
was made (Wang et al., 2010). Also TTR-33 is predicted to be a secreted protein, but seems to 
be produced by the posterior arcade cells in the head. So could TTR-33 act as a in a hormone-
like manner? There are certainly examples of proteins that are secreted to act on tissues in 
other parts of the worm: The growth factor SVH-1 (suppressor of vhp-1 deletion lethality) is 
secreted from sensory ADL neurons and regulates axon regeneration (Li et al., 2012), and the 
transcription factor SKN-1 is thought to trigger the secretion of hormones from a pair of 
neurons to promote longevity (Bishop and Guarente, 2007).  
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We aim to determine if TTR-33 acts in the posterior arcade cells and if it functions as a 
secreted protein by expressing the TTR-33 protein from a promoter that is specific for the 
posterior arcaded cell (Pbath-15) with and without its secretion signal. The 6 posterior arcade 
cells form a syncytium and link the digestive tract to the epidermis (Portereiko and Mango, 
2001), however there is not much known about their function after embryonic development. 
The arcade cells contain many free ribosomes and mitochondria, but very little endoplasmic 
reticulum (Wright and Thomson, 1981), features that was also reported for lymphocytes and 
antigen-presenting cells (Young et al., 2013). Antigen-presenting cells are crucial for the 
activation of lymphocytes – macrophages, dendritic cells and B lymphocytes – to trigger an 
adaptive immune response (Young et al., 2013). The similarity between the TTR-33-expressing 
cells and mammalian immune cells supports our hypothesis that TTR-33 could be part of a 
hormone-like immune response. Just prior to larval moulting, the arcade cells contain dense 
core vesicles and it was suggested that they could form a new cuticle by vesicle secretion 
(Wright and Thomson, 1981). In addition, the posterior arcade cells were reported to express 
pha-4 (defective pharynx development) – a FoxA transcription factor with a role dietary-
restriction-induced longevity (Antebi, 2013), possibly pha-1 (Kuzmanov et al., 2014), agr-1 
(Agrin (synaptic protein) – a secretion signal-containing protein with a vertebrate orthologue 
functioning in the development and maintenance of neuromuscular junction) (Hrus et al., 
2007), and a few hedgehog-like genes (Hao et al., 2006). 
To test if ttr-33 – similar to ttr-52 – acts via the phagocytosis pathway, we created several 
double mutants for epistasis experiments. It is not known how dopaminergic neurons die after 
exposure to 6-OHDA, but we found that inhibition of engulfment leads to a decrease in 
neuronal loss in wild-type animals and ttr-33 mutants. We note that a review about 
mammalian 6-OHDA models (Kostrzewa and Jacobowitz, 1974) and the paper that introduced 
the C. elegans 6-OHDA model (Nass et al., 2002) indicated that after 6-OHDA intoxication, 
dopaminergic neurons are surrounded by microglia or phagocytes, respectively. These reports 
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support the ideas that dopaminergic neurons might be engulfed after being damaged by 6-
OHDA. To our knowledge, it is not clear how dopaminergic neurons die in PD patients. 
However, it was suggested that pdr-1 − the C. elegans homologue of the E3 ligase and PD risk 
gene parkin − tags the key phagocytosis protein CED-10 for degradation, therewith preventing 
engulfment of apoptotic cells (Cabello et al., 2014). This would mean that mutation of pdr-
1/parkin could lead to increased phagocytosis. We will follow up this line of research by using 
the ced-2;ced-6 double mutant. With this strain, we can investigate if inhibition of the two 
partially redundant engulfment pathways (here represented by ced-2 and ced-6) leads to 
similarly strong effects as a mutation of the common target ced-10 in wild-type and ttr-33 
mutant background. Furthermore, we can investigate if dying dopaminergic neurons expose 
phosphatidylserine (PS) on their surface by using the PS reporters MFG-E8::GFP, Annexin 
V::GFP or GFP::lactadherin (Conradt et al., 2016). Also, the only known C. elegans receptor on 
phagocytosis cells is CED-1/MEGF10, and we will determine if a CED-1::GFP fusion accumulates 
around dopaminergic neurons after 6-OHDA exposure. If CED-1 indeed surrounds damaged 
dopaminergic neurons, and if TTR-33 truly acts as a bridge between dying dopaminergic 
neurons and engulfing cells, we would expect that CED-1 accumulates later than TTR-33 and 
that the CED-1 signal is reduced in the ttr-33 mutant. Also, if TTR-33 surrounds dying cells, it is 
expected that interfering with dopaminergic neuron loss – most likely a necrosis-like cell death 
(see below) – would diminish its localisation. We note that microglia were reported to be 
activated in Parkinson’s disease (Heneka et al., 2014) and that the C. elegans 6-OHDA model 
might therefore indeed recapitulate important features of this disease.  
7.14 The apoptosis pathway and its role in organismal protection 
As stated before, it is not known how dopaminergic neurons die after 6-OHDA intoxication and 
they do not seem to undergo apoptosis. Mutations in the core apoptosis pathway do not 
prevent cell loss (Nass et al., 2002), but we find that inhibition of apoptosis rather leads to a 
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loss of protection against 6-OHDA. It has been reported in that the intrinsic apoptosis pathway 
in C. elegans can sense mitochondrial reactive oxygen species (mtROS) to modulate stress 
sensitivity and survival (Yee et al., 2014). In the same paper, glit-1 expression was increased 
under three different mtROS-inducing conditions which extended C. elegans lifespan. Since we 
find increased 6-OHDA sensitivity of ced-4, ced-3 and ced-13 mutants, the mtROS-sensing 
pathway might be involved in the reaction to 6-OHDA-induced oxidative stress. However, we 
still need to investigate if these genes also have protective effects wild-type degeneration at 
higher concentrations of 6-OHDA.  
7.15 Indications for a 6-OHDA-induced necrotic cell death of dopaminergic neurons 
Apart from apoptosis, necrosis is a main type of cell death and there are indications that 
dopaminergic neurons become necrotic after 6-OHDA intoxication. Previously, it was shown 
that C. elegans dopaminergic CEP neurons undergo necrosis after heat shock and that cell loss 
can be alleviated by mutating the calcium-binding chaperone crt-1 (Kourtis et al., 2012). crt-1 
was shown to be upregulated upon tunicamycin exposure and this was dependent on the UPR 
gene ire-1 (Lee et al., 2007a). Since crt-1 appears to have a role in necrosis, we tested if it also 
modulates the extent of 6-OHDA-induced dopaminergic neurodegeneration. We did not find 
greatly increased sensitivity to 6-OHDA for crt-1 mutants, but we still need to test if the 
mutation influences dopaminergic neurodegeneration in wild-type animals at higher 
concentrations of the drug. Remarkably, crt-1;glit-1 double mutants seem to be synthetic 
lethal and we aim to generate the ttr-33;crt-1 double mutant. In addition, we want to 
determine if Ca2+ homeostasis in general has a role in 6-OHDA-induced neurodegeneration. 
Pharmacologically, cellular Ca2+ levels can be decreased with the Ca2+-specific chelator EGTA, 
by preventing Ca2+ release from ER stores with dantrolene − or increased by inhibiting Ca2+ 
uptake and stimulation of Ca2+ release from ER stores with thapsigargin (Xu et al., 2001). 
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Genetically, Ca2+ release from the ER can be diminished by mutating the inositol triphosphate 
receptor itr-1 (Xu et al., 2001).  
The aspartyl proteases ASP-3 and ASP-4 and the Ca2+-dependent proteases CLP-1 and TRA-3 
were shown to mediate necrosis (Syntichaki et al., 2002) and could be tested for their 
influence on 6-OHDA-induced neurodegeneration. Furthermore, transcriptional levels of those 
proteases can be tested in wild-type and mutant worms with and without 6-OHDA treatment. 
As mentioned above, 6-OHDA-induced neurodegeneration is reduced under conditions of 
starvation. Furthermore, nutrient deprivation leads to drop of aspartyl protease activity to 5-
10 % of that of well-fed nematodes (Hawdon et al., 1989; Jacobson et al., 1988; Syntichaki et 
al., 2002). Therefore, these proteases could indeed mediate a necrosis-like cell death of 
dopaminergic neurons upon treatment with 6-OHDA. We note that GLIT-1 possesses two 
aspartates in the active site of its carboxyesterase-like domain; hence GLIT-1 could possibly act 
as an aspartyl protease itself.  
Necrosis can be facilitated by autophagy (Samara et al., 2008; Troulinaki and Tavernarakis, 
2011) and autophagy was shown to contribute to 6-OHDA-induced dopaminergic cell death 
(Tóth et al., 2007). This further supports the idea that dopaminergic neurons might undergo a 
necrosis-like cell death upon treatment with 6-OHDA.  
It is possible that we find that dopaminergic neurons neither undergo apoptosis nor a necrosis-
like cell death after intoxication with 6-OHDA. However, there might be a third possibility such 
that phagocytosis itself was shown to contribute to cell killing in C. elegans (Chakraborty et al., 
2015; Hoeppner et al., 2001; Reddien et al., 2001). Remarkably, the authors also found that in 
some cases, cell death seems to be reversible until reaching a certain stage (Hoeppner et al., 
2001). 
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7.16 Neuronal axon regeneration might be mediated by a similar pathway as the 
protection against 6-OHDA 
Recently, C. elegans has become a model for neuronal regeneration, a process which seems to 
involve the ttr-33 paralogue ttr-52. After cutting axons in L4 stage animals with a laser, the 
regrowth of the processes can be followed over time. Remarkably, several aspects of axon 
regeneration are conserved between C. elegans and vertebrates (El Bejjani and Hammarlund, 
2012). The C. elegans PS receptor PSR-1 was shown to act in a pathway with TTR-52, CED-5, 
NRF-5 and CED-6 to promote axon regeneration in the PLM neurons and the authors 
speculates that extracellular vesicle generation (see below) could play a role in this process 
(Neumann et al., 2014). In addition, several of the genes which we found to be involved in 6-
OHDA-induced neurodegeneration also seem to have a role in axon regeneration: The 
apoptosis genes CED-3 and CED-4, the calreticulin CRT-1, the JNK kinase KGB-1 (Pinan-Lucarre 
et al., 2012) and the neuroligin NLG-1 (Nix et al., 2014) were reported to promote 
regeneration, whereas the JNK kinase JNK-1 (Hammarlund et al., 2009) and IRE-1 (Nix et al., 
2014) seem to inhibit it. However, the studies investigated different types of neurons and a 
few genes seem to have an effect in some paradigms but not in others. To our knowledge, the 
axons of dopaminergic neurons have not been tested for regeneration, but it was suggested 
that the regeneration of dopaminergic dendrites depends on similar pathways (González-Hunt 
et al., 2014). We speculate that 6-OHDA and a laser cut might inflict a comparable injury to the 
dopaminergic neurons and that related protective pathways are triggered.  
7.17 Could TSP-17-containing extracellular vesicles provide a ‘find-me’ signal 
stimulating the phagocytosis of dopaminergic neurons? 
To faciliate cell corpse engulfment, phosphatidylserine (PS) exposed on the surface of 
apoptotic cells might be transmitted to phagocytes via extracellular vesicles (exosomes) and 
this process seems to be regulated by TTR-52, NRF-5 and CED-7 (Mapes et al., 2012). We 
hypothesise that TTR-33 might exert a similar function like TTR-52 and mediate the removal of 
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PS from the surface of necrotic dopaminergic neurons via small vesicles. Hence, loss of ttr-33 
function might lead to accumulation of the ‘eat-me’ mark, such that the cells are engulfed 
prematurely after 6-OHDA exposure.  
We speculate that the previously characterised tetraspanin tsp-17, for which mutation also 
causes sensitivity to 6-OHDA (Masoudi et al., 2014), could also function in dopaminergic cell 
recognition and/or extracellular vesicle generation. TSP-17 acts in dopaminergic neurons 
(Masoudi et al., 2014) and is a transmembrane protein like GLIT-1. Tetraspanins were shown to 
function in the immune system and to contribute to pathogen infection and the formation of 
metastasis (Charrin et al., 2014). Many tetraspanins interact directly with specific proteins, 
including other tetraspanins, generating a network of interactions. We note that several 
tetraspanins contain a PDZ-binding motif (Charrin et al., 2014), similar to neuroligins. 
Furthermore, tetraspanins are thought to contribute to membrane compartmentalisation 
(Charrin et al., 2014). Tetrasspanins are the most abundant membrane protein of extracellular 
vesicles and have been proposed as possible exosome markers (Andreu and Yáñez-Mó, 2014). 
Extracellular vesicles have a defined protein signature, comprising conserved as well as cell 
type specific sets of proteins (Andreu and Yáñez-Mó, 2014). We hypothesise that the 
tetraspanin TSP-17 – and possibly the neuroligin-like gene GLIT-1 – might mediate the 
formation of exosomes originating from dopaminergic neurons after 6-OHDA-induced damage. 
The phagocytosis of a cell is promoted by a combination of released and exposed signals – 
‘find-me’ and ‘eat-me’ signals, respectively. Exosomes might represent a ‘find-me’ signal 
originating from dopaminergic neurons that were damaged by 6-OHDA. 
There are additional links between the tetraspanin tsp-17, the neuroligin-like glit-1 and the 
phagocytosis pathway. Tetraspanins functionally regulate several membrane-bound proteases, 
including the exit of the metalloproteinase ADAM10 from the endoplasmic reticulum and its 
targeting to the plasma membrane (Charrin et al., 2014). This might be of importance since 
95 
 
this protease was shown to cleave neuroligin-1 to generate a secreted extracellular fragment 
(Suzuki et al., 2012). Furthermore, connections between tetraspanins and the engulfment 
pathway were reported: The tetraspanin CD63 was suggested to interact with the small 
GTPase Rac1 (Charrin et al., 2014). The C. elegans homologue of Rac1 is CED-10 – the protein 
on which the two partially redundant phagocytosis pathways merge. In addition, the 
tetraspanins CD9 and CD81 were shown to cooperate to negatively regulate macrophage 
fusion (Charrin et al., 2014).   
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8 MATERIAL AND METHODS 
8.1 C. elegans strains and maintenance 
Strains were grown at 20°C unless indicated otherwise and N2 Bristol and BY200 (pdat-1::gfp, 
originally generated by the Blakely lab (Nass et al., 2002)) were used as wild-type strains. wdr-
23(tm1817), tsp-17(tm4994) and pink-1(tm1779) mutants were generated and kindly provided 
by Shohei Mitani of the National Bioresource Project (NBRP) 
(http://shigen.nig.ac.jp/c.elegans/). Details of these alleles are described by the National 
Bioresource Project. Additional information about alleles in this study is provided by 
WormBase (www.wormbase.org). Strains from the Caenorhabditis Genetics Center (CGC) or 
the NBRP were outcrossed to the BY200 strain to eliminate unlinked mutations and to 
introduce a green fluorescent protein (GFP) marker for dopaminergic neurons. Isolated 
mutants were outcrossed a minimum of six times to the BY200 strain. 
Table 1: List of C. elegans strains from this study 
BY200 vtIs1[pdat-1::gfp; rol-6] V 
TG4100 vtIs1 V; glit-1(gt1981) X 
TG4101 vtIs1 V; glit-1(gk384527) X 
TG4102 vtIs1 V; glit-1(ok237) X 
TG4103 ttr-33(gt1983) V; vtIs1 V 
TG4104 ttr-33(gk567379) V; vtIs1 V 
TG2400 dat-1(ok157) III; vtIs1 V 
TG4105 dat-1(ok157) III; vtIs1 V; glit-1(gt1981) X 
TG4106 dat-1(ok157) III; ttr-33(gt1983) V; vtIs1 V 
N2 Bristol  
TG4107 dvIs19 [(pAF15)pgst-4::gfp::NLS] III 
SJ4005 zcIs4 [hsp-4::gfp] V 
SJ4100 zcIs13 [hsp-6::gfp] V 
TG4108 dvIs19 [(pAF15)pgst-4::gfp::NLS] III; glit-1(gt1981) X 
TG4109 zcIs4 [phsp-4::gfp] V; glit-1(gt1981) X 
TG4110 zcIs13 [phsp-6::gfp] V; glit-1(gt1981) X 
TG4111 skn-1(zu67) IV/nT1 [unc-?(n754) let-?] (IV;V); vtIs1 V; 
TG4112 skn-1(zu67) IV/nT1 [unc-?(n754) let-?] (IV;V); vtIs1 V; glit-1(gt1981) 
TG4113 skn-1(lax120); vtIs1 V; 
TG4114 skn-1(lax120); vtIs1 V; glit-1(gt1981) X 
TG4115 wdr-23(tm1817) I; vtIs1 V; 
TG4116 wdr-23(tm1817) I; vtIs1 V; glit-1(gt1981) X 
TG4117 ire-1(v33) II; vtIs1 V; 
TG4118 ire-1(v33) II; vtIs1 V; glit-1(gt1981) X 
TG4119 ire-1(v33) II; ttr-33(gt1983) V; vtIs1 V 
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TG4120 pmk-1(km25) IV; vtIs1 V 
TG4121 pmk-1(km25) IV; ttr-33(gt1983) V; vtIs1 V 
TG4122 jnk-1(gk7) IV; vtIs1 V 
TG4123 jnk-1(gk7) IV; ttr-33(gt1983) V; vtIs1 V 
TG4124 pmk-3(ok169) IV; vtIs1 V 
TG4125 pmk-3(ok169) IV; ttr-33(gt1983) V; vtIs1 V 
TG4126 kgb-1(ok169) IV; vtIs1 V; 
TG4127 kgb-1(ok169) IV; vtIs1 V; glit-1(gt1981) X 
TG4128 pmk-1(km25) IV; vtIs1 V; glit-1(gt1981) X 
TG4129 jnk-1(gk7) IV; vtIs1 V; glit-1(gt1981) X 
TG4130 pmk-3(ok169) IV; vtIs1 V; glit-1(gt1981) X 
TG2436 vtIs1 V; tsp-17(tm4995) X  
TG4131 vtIs1 V; tsp-17(tm4995) X; glit-1(gt1981) X 
TG4132 ttr-33(gt1983) V; vtIs1 V; tsp-17(tm4995) X 
TG4133 ttr-33(gt1983) V; vtIs1 V; glit-1(gt1981) X  
TG4134 ttr-33(gt1983) V; vtIs1 V; glit-1(gt1981) X; tsp-17(tm4995) X  
TG4135 vtIs1 V; nlg-1(ok259) X  
TG4136 vtIs1 V; glit-1(gt1981) X; nlg-1(ok259) X 
TG4137 vtIs1 V; nrx-1(ok1649) X 
TG4138 vtIs1 V; glit-1(gt1981) X; nrx-1(ok1649) X 
TG4139 vtIs1 V; nrx-1(wy778) X 
TG4140 vtIs1 V; glit-1(gt1981) X; nrx-1(wy778) X 
TG2410 vtIs1 V; dop-1(vs100) X 
TG4141 vtIs1 V; dop-1(vs100) X; glit-1(gt1981) X 
TG2412 dop-2(vs105) V; vtIs1 V 
TG4142 dop-2(vs105) V; vtIs1 V; glit-1(gt1981) X 
TG2414 vtIs1 V; dop-3(vs106) X 
TG4143 vtIs1 V; glit-1(gt1981) X; dop-3(vs106) X 
TG4144 dop-2(vs105) V; vtIs1 V; dop-1(vs100) X 
TG4145 dop-2(vs105) V; vtIs1 V; dop-1(vs100) X; glit-1(gt1981) X 
TG4146 vtIs1 V; dop-1(vs100) X; dop-3(vs106) X 
TG4147 vtIs1 V; dop-1(vs100) X; glit-1(gt1981) X; dop-3(vs106) X 
TG2466 dop-2(vs105) V; vtIs1 V; dop-3(vs106) X 
TG4148 dop-2(vs105) V; vtIs1 V; glit-1(gt1981); dop-3(vs106) X 
TG2415 dop-2(vs105) V; vtIs1 V; dop-1(vs100) X; dop-3(vs106) X 
TG4149 dop-2(vs105) V; vtIs1 V; dop-1(vs100) X; glit-1(gt1981) X; dop-3(vs106) X 
TG2396 bas-1(ad446) III; vtIs1 V 
TG4150 bas-1(ad446) III; vtIs1 V; glit-1(gt1981) X 
TG2399 vtIs1 V; cat-1(ok411) X 
TG4151 vtIs1 V; glit-1(gt1981) X; cat-1(ok411) X 
TG2395 cat-2(e1112) II; vtIs1 V;  
TG4152 cat-2(e1112) II; vtIs1 V; glit-1(gt1981) X 
TG4153 otIs433 [dat-1::NLS::RFP ttx-3::mCh] V; PExglit-1::GFP 
TG4154 ced-2(e1752) IV; vtIs1 V;  
TG4155 ced-2(e1752) IV; ttr-33(gt1983) V; vtIs1 V;  
TG4156 ced-6(n1813) III; vtIs1 V;  
TG4157 ced-6(n1813) III; ttr-33(gt1983) V; vtIs1 V;  
TG4158 ced-10(n3246) IV; vtIs1 V;  
TG4159 ced-10(n3246) IV; ttr-33(gt1983) V; vtIs1 V;  
TG4160 ttr-52(sm211) III; vtIs1 V;  
TG4161 ttr-52(sm211) III; ttr-33(gt1983) V; vtIs1 V;  
TG4162 crt-1(ok948) V; vtIs1 V;  
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TG4163 ced-4(n1162) III; vtIs1 V;  
TG4164 ced-4(n1162) III; ttr-33(gt1983) V; vtIs1 V;  
TG4165 ced-4(n1162) III; vtIs1 V; glit-1(gt1981) X 
TG4166 ced-3(n717) IV; vtIs1 V;  
TG4167 ced-3(n717) IV; vtIs1 V; glit-1(gt1981) X 
TG4168 vtIs1 V; ced-13(sv32) X; 
TG4169 vtIs1 V; glit-1(gt1981) X; ced-13(sv32) X; 
TG4170 PExttr-33::GFP 
TG4171 vtIs1 V; CB4856 
TG4172 pink-1(tm1779) II; vtIs1 V;  
TG4173 pink-1(tm1779) II; vtIs1 V; glit-1(gt1981) X 
TG4174 pdr-1(gk448) III; vtIs1 V;  
TG4175 pdr-1(gk448) III; vtIs1 V; glit-1(gt1981) X 
 
 
8.1 Mutagenesis and mapping 
L4 and young adult staged BY200 worms in M9 buffer were mutagenised with 25 mM ethyl 
methanesulfonate (EMS) for 4 h at 20°C, washed and let incubated at 15°C overnight. After the 
first egg-laying the worms were bleached and the F1 progeny let hatch overnight in M9. This 
synchronised F1 were left to develop on seeded plates until they reached early adult stage. 
The F1 adults were washed off in M9 again to lay a synchronised population of F2 L1 larvae 
which was treated with 10 mM 6-OHDA and screened for dopaminergic neuron loss after 72 h. 
Candidates were picked on separate plates, backcrossed at least three times and re-tested for 
their hypersensitivity to 6-OHDA. The genomic DNA was sent for whole-genome sequencing 
and SNP mapping was done as previously described (Doitsidou et al., 2010; Minevich et al., 
2012). 
8.2 Stress assays 
To obtain synchronized L1 larvae for the paraquat and 6-OHDA assays, 1–10 adult worms 
were incubated to lay eggs in 70 µl M9 without food on a benchtop shaker at 20˚C, 500 rpm 
for 24-30 h. Due to the swimming-defect of tsp-17(tm4995), L1 larvae for experiments 
including this strain were obtained by filtering a mixed population of worms that was washed 
off the plates.  
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For 6-OHDA assays, 10 µL 200 mM ascorbic acid and 10 µL of the respective 6-OHDA 5 x stock 
concentration were added to 30 µL of L1-stage larvae in M9. After 1 hour incubation at 20˚C 
and shaking at 500 rpm, 150 µL M9 buffer was added to oxidise and inactivate the 6-OHDA. 
The worms were pipetted to one half of an NGM plate containing a stripe of OP50 bacteria on 
the opposite half of the plate and adult worms and eggs were picked off to prevent growth of 
animals that were not intoxicated at L1 stage. Plates were incubated at 20˚C before examining 
the 6-OHDA-induced degeneration in a blinded manner (i.e. without the experimentator’s 
knowledge of the animals’ genotype) using a Leica fluorescent dissecting microscope. For 
intoxication of different developmental stages, the respective stages were picked after 6-
OHDA treatment from a mixed population of worms. 
For paraquat assays, 10 µL of the respective 5x paraquat stock concentration was added to 40 
µL of L1-stage larvae in M9. After 1 h incubation in the shaker 150 µL M9 buffer was added and 
the L1 larvae were counted after pipetting them to a seeded NGM plate. Surviving worms were 
counted again after 24 h.  
For tunicamycin assays, gravid adults were put on seeded plates containing the indicated 
concentration of tunicamycin to let lay eggs for 1-2 h to get around 50 eggs per condition. The 
eggs were counted immediately after removing the adults. 48 h after egg-laying, the 
development of the larvae was determined.  
For Hygromycin B assays, unstarved L1 stage larvae were filtered and approximately 100 
worms per condition put on seeded plates containing the indicated concentration of 
tunicamycin. The larvae were counted immediately after plating and 48 h afterwards.  
8.1 Behavioural assays 
All behavioural assays were performed in a blinded manner.  
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For lifespan assays, 50 L4 worms were picked per strain and moved to new plates every day 
during the first 6 days and then only to avoid mixing with the progeny. Worms that did not 
move after touch with a platinum pick were scored as dead. Dead worms were counted and 
removed every day and bag of worms and dry and burst worms were censored. The data was 
analysed using OASIS (Online application for Survival Analysis, http://sbi.postech.ac.kr/oasis/) 
(Yang et al., 2011). 
Dopamine paralysis assays were carried out as previously described (Sanyal et al., 2004). 
Staged adult animals were incubated for 20 min on a plate containing dopamine and assessed 
for their ability to complete body movement through minimum and maximum amplitude 
during a 5 s observation period. Two plates containing 25 worms each were assessed for each 
condition. 
For the swimming-induced paralysis (SWIP) assay 5-15 L4 stage larvae were picked into a 
glass well in 40 μL water. The number of paralysed worms scored using a Leica dissecting 
microscope every minute for 30 minutes (McDonald et al., 2007). 
Basal slowing assays were done by Eline Jongsma as previously described (Chase et al. 2004). 
NGM plates were prepared and half of them seeded with HB101 bacteria before incubating 
them at 37°C overnight. Also, mid-L4 larvae were picked on separate plates. The next day, 
these staged young adult animals were put in 40 μL M9 for 2 min for washing and then picked 
to the centre of a plate. 6 animals each were put on a plate with and without bacteria, 
respectively. After a 2 min adaptation time, the locomotion rates of each animal was 
quantified by counting the number of body bends completed in five consecutive 20 s intervals. 
The experiment was done twice on different days. 
For each mutant in the egg-laying assay (done by Eline Jongsma), eggs were counted by from 
total of 9 adult worms on 3 different plates after 3 hours of egg-laying.  
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8.2 Bioinformatic analysis  
GLIT-1 and TTR-33 extra- and intracellular and transmembrane domains and signal peptides 
were predicted with Phobius (http://phobius.sbc.su.se/) (Käll et al., 2007). 
GLIT-1 and TTR-33 protein structure models were calculated in SWISS-MODEL 
(swissmodel.expasy.org) (Biasini et al., 2014) and visualised with Swiss-PdbViewer 4.1.0 
(http://www.expasy.org/spdbv/) (Guex and Peitsch, 1997). 
For phylogenetic analysis of GLIT-1, CLC workbench Version 7.6.4 was used to align protein 
sequences (Default parameters: Gap open cost 10.0, Gap extension cost 1.0, End gap cost as 
any other, Alignment very accurate (slow)) and create a the tree (Tree construction method: 
Neighbour Joining, Protein distance measure: Jukes-Cantor, Bootstrapping: 100 Replicates).  
For GLIT-1 PDZ domain binding prediction, the webserver POW was used 
(http://webservice.baderlab.org/domains/POW/). Predictions are made using a support vector 
machine (SVM) that was trained using experimentally determined PDZ interaction data from 
protein microarray and phage display experiments for mouse and human. Two types of 
predictors were used, a sequence-based one (Hui and Bader, 2010) – which was trained using 
domain and peptide sequence features – and a structure-based one (Hui et al., 2013) – which 
was trained using domain structure and peptide sequence features. 
For C. elegans TTR phylogenetic alignment Jalview Version 2.9.0b2 (www.jalview.org) was 
used for alignment (ClustalWS version 2.0.12 with default settings) and visualisation 
(Waterhouse et al., 2009). TTR-33 secondary structure prediction was done with JPred4 
(Drozdetskiy et al., 2015) in Jalview (Troshin et al., 2011).  
For ttr-33 correlated gene expression analysis, SPELL (Serial Pattern of Expression Levels 
Locator) Version 2.0.3.r71 was used (http://spell.caltech.edu:3000/). Given a query gene, 
SPELL searches for genes with correlated expression patterns based on available microarray, 
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RNAseq and tiling array data (currently 5264 experiments in 315 datasets). The main algorithm 
is described in (Hibbs et al., 2007). 
8.3 Statistical analysis 
The two-tailed t-test and were performed with the Analysis ToolPak Add-In in Microsoft Excel 
2010. To choose a t-test assuming equal or unequal variances, respectively, an F-test was 
conducted beforehand, also with the Analysis ToolPak Add-In.  
To compare 6-OHDA intoxication data, a G-Test was performed with R Studio 1.0.44 DescTools 
descriptive statistics tools package. p-values were calculated for each biological replicate and 
for the pooled biological replicate data, and the least significant of these p-values indicated in 
the graphs. Unless otherwise indicated, data is only marked as significant if all replicates and 
the pooled replicate data were found to be significant.  
8.4 DNA cloning and generation of transgenic lines 
For generation of transgenic constructs, genomic DNA was amplified with PCR primers 
containing additional 8 base pair restriction sites to achieve the following design: AscI – 
Promoter – SgfI – Gene – NotI – Fluorescent tag – FseI – 3’UTR – PacI. The ttr-33 translation 
construct (9287374654767326 H09) was acquired from C. elegans TransgeneOme Resource 
(MPI-CBG) (Sarov et al., 2012). 
Table 2: Plasmids and primers. 
Restriction sites are shown in italics, translation start and end sites in bold. Translation codons 
are separated by a space.  
glit-1 transcriptional construct (Pglit-1::GFP) for Chr IV 
AscI – Pglit-1 – NotI – GFP – FseI – 3’glit-1– PacI  
AscI_Pglit-1 GCTAggcgcgccGTATCTGGCATTGGCTCG 
Pglit-1_Not-1 GCTA gcg gcc gca CATTCCATGTGACGCGAT 
NotI_GFP GCTAgc ggc cgc AGT AAA GGA GAA GAA CTT TTC ACT GG 
103 
 
GFP_FseI(Glit-1) AAGTTA ggc cgg ccc CTT GTA TGG CCG GCT AG 
FseI(GFP)_3'GLIT-1 AC AAG ggg ccg gcc TAACTTTCAAAGTTTGTAAATAATGTATAATTTA 
3'GLIT-1_Pac-1 GCTAttaattaaCCAGTTGCAGTGTTTTTTTG 
 
ttr-33 transcriptional construct (Pttr-33::GFP) for Chr IV 
AscI – Pttr-33 – NotI – GFP – FseI – 3’ttr-33 – PacI  
AscI_Pttr-33 GCTAggcgcgccCAAAGAAACTTGCGTGTTTC 
Pttr-33_NotI GCTA gcg gcc gca CATTATTTTTGTCTGAAAATACAAACAC 
NotI_GFP GCTAgc ggc cgc AGT AAA GGA GAA GAA CTT TTC ACT GG 
GFP_FseI(ttr-33) TTATTA ggc cgg ccc CTT GTA TGG CCG GCT AG 
FseI(GFP)_3'TTR-33 AC AAG Ggg ccg gcc TAATAATTATACTTAAAAGTATTTTCAACTG 
3'TTR_33-PacI GCTAttaattaaGCATGCATCTTCCCATAAAAG 
 
 
8.1 Microscopy 
Images were acquired using a Deltavision (Applied Precision) microscope and deconvolved 
using the softWoRx Suite (Applied Precision). 
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9 SUPPLEMENTARY INFORMATION 
Table S 1: PDZ domain proteins that are predicted to interact with the GLIT-1 PDZ binding 
sequence based on sequence information.  
The algorithm of the POW website predicts interactors of the GLIT-1-specific C-terminal PDZ 
binding sequence from 85 C. elegans-specific PDZ proteins based on sequence information. 
Proteins were sorted based on the support vector machine (SVM) decision score – measure of 
predictor confidence in the prediction. In the last row, selected information from WormBase was 
added. *Asterisk denotes domains with low similarity (<0.6) to the training set domains, as 
measured by binding site sequence similarity. Therefore the predictions may be less reliable. 
 
PDZ Domain 
Name 
SVM 
Decision 
Score 
Wormbase information 
TAG-60-1* 0.758 
NRFL-1, NHERF (mammalian Na/H Exchange Regulatory Factor) 
Like) – homologue of Drosophila SIP1 that maintains epithelial 
integrity, required for normal acetylcholine neurotransmission 
SHN-1-1 0.551 SHaNk (SH3/ankyrin domain scaffold protein) related – sole C. elegans SHANK protein and orthlogue of vertebrate SHANK3  
STN-2-1 0.54 SynTrophiN – encodes a gamma-syntrophin 
F30F8.3-1* 0.489 GRAS-1, GRASP (General Receptor for phosphoinositides 1- Associated Scaffold Protein) homolog 
TAG-60-2* 0.422 see above 
MPZ-1-6 0.378 Multiple PDZ domain protein  
CNK-1-1* 0.299 Connector/eNhancer of KSR 
MICS-1-1 0.29 
MItoChondrial Scaffolding protein- orthologue of human 
SYNJ2BP (synaptojanin 2 binding protein) – microarray and 
RNA sequencing studies indicate that mics-1 is regulated by 
cyc-1, sir-2.1, cep-1; microarray studies indicate that mics-1 is 
regulated by Paraquat; 
MAGI-1-4* 0.236 
MAGI (Membrane Associated Guanylate kinase Inverted) 
homologue – multi PDZ-domain containing tight junction-
associated protein: MAGIs are members of vertebrate 
membrane associated guanylate-kinase (MAGUK) family; 
MAGI-1/S-SCAM is also a broadly conserved synaptic 
scaffolding molecule 
MPZ-1-7* 0.161 see above 
ZK849.2-2 0.13 GOPC-1 (GOlgi-associated PDZ and Coiled-coil motif protein) – orthologue of human GOPC 
C50D2.3-1* 0.036 
Microarray and RNA sequencing studies indicate that C50D2.3 
is regulated by wdr-23, isp-1, and nuo-6; microarray studies 
indicate that C50D2.3 is regulated by Paraquat 
MAGI-1-2 0.031 see above 
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Table S 2: PDZ domain proteins that are predicted to interact with the GLIT-1 PDZ binding 
sequence based on structure information.  
The algorithm of the POW website predicts interactors of the GLIT-1-specific C-terminal PDZ 
binding sequence from 64 C. elegans-specific PDZ proteins based on structure information. 
Proteins were sorted based on the support vector machine (SVM) decision score – measure of 
predictor confidence in the prediction. In the last row, selected information from WormBase was 
added.  
 
PDZ Domain 
Name 
SVM 
Decision 
Score 
Wormbase information 
DLG-1-2 1.443 
Drosophila Discs LarGe homologue – MAGUK protein, DLG-1 is 
physically located at apical adherens junctions in all epithelia and 
is required for organisation of the embryonic gut epithelium into 
a coherent tube. 
LIN-10-2 0.896 
abnormal cell LINeage – homologous to mammalian Munc 
interacting proteins and required for polarized protein 
localisation 
MPZ-1-4 0.865 see table above 
F44D12.1-1 0.744 MAGU-4 (MAGUK family) – orthologue of human DLG5 (discs large 5 (Drosophila)) 
MICS-1-1 0.671 see table above 
DLG-1-1 0.666 see above 
STN-1-1 0.648 
SynTrophiN – encodes a syntrophin with homology to vertebrate 
α and beta-syntrophins; STN-1 physically interacts with the SNF-6 
acetylcholine transporter 
DSH-1-1 0.599 
DiSHevelled related – homologue of Drosophila DISHEVELED, 
functions as part of a Wnt signaling pathway that regulates ACR-
16 (Acetylcholine receptor)localisation to postsynaptic regions, a 
key component of activity-dependent synaptic plasticity 
C35D10.2-1 0.597 GIPC-1 (RGS-GAIP Interacting Protein C) homolog 
NAB-1-1 0.594 NeurABin,  
MPZ-1-6 0.524 see table above 
SHN-1-1 0.512 see table above 
MAGI-1-4 0.509 see table above 
FRM-5-2 0.426 FERM domain (protein4.1- ezrin-radixin-moesin) family  
ZOO-1-1 0.356 ZO-1 (Zonula Occludens tight junctional protein) Ortholog 
TAG-60-2 0.339 see table above 
KIN-4-1 0.264 protein KINase – orthologue of MAST (microtubule associated serine/threonine) kinases 
AFD-1-1 0.253 
AFaDin (actin filament binding protein) homologue – microarray 
and RNA sequencing studies indicate that afd-1 is regulated by 
cyc-1, sir-2.1, slr-2, fbf-1, isp-1, and nuo-6; RNA sequencing and 
microarray studies indicate that afd-1 is regulated by Rotenone 
and Paraquat 
TAG-60-1 0.253 see table above 
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F30F8.3-1 0.251 see table above 
PTP-1-1 0.234 Protein Tyrosine Phosphatase  
F44D12.4-1 0.233 GIPC-2 (RGS-GAIP Interacting Protein C) homolog 
SYD-1-1 0.231 SYnapse Defective  
T19B10.5-1 0.216 protein with partial similarity to human PERIAXIN 
MPZ-1-8 0.206 see table above 
MPZ-1-10 0.203 see table above 
FRM-5-3 0.197 FERM domain (protein4.1- ezrin-radixin-moesin) family 
PAR-3-3 0.181 abnormal embryonic PARtitioning of cytoplasm 
PAR-6-1 0.179 abnormal embryonic PARtitioning of cytoplasm 
MAGI-1-5 0.112 see table above 
STN2-1 0.098 see table above 
MPZ-1-2 0.086 see table above 
TAG-117-1 0.071 MAGU-1  
MAGI-1-3 0.055 see table above 
ZK1321.4-1 0.054 microarray, tiling array, proteomic, and RNA sequencing studies indicate that ZK1321.4 is regulated by cyc-1, daf-16; 
RHGF-1-1 0.037 
RHo Guanine nucleotide exchange Factor – RHGF-1 functions 
within cholinergic motor neurons in one of four G-protein-
mediated signaling pathways that control locomotion via 
regulation of acetylcholine (ACh) release at neuromuscular 
junctions 
ZOO-1-3 0.026 see above 
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Table S 3: Gene Ontology (GO) term analysis for genes for which expression pattern correlated 
with ttr-33. 
Genes with expression patterns that correlated to the ttr-33 expression pattern were predicted 
using SPELL – Nematodes and their GO terms are listed below sorted by P value. The number of 
genes that are associated with this GO term out of all genes with a similar expression pattern to 
ttr-33 and out of all genes in the genome are shown in column % Query and % genome, 
respectively. Very specific processes that are associated with few genes in the genome are marked 
in red. * Similar GO terms based on the same group of genes were merged.  
GO Term P value % Query % Genome Annotated Genes 
neuropeptide 
signaling pathway  5.21E-08 7 of 41 
188 of 
54514 
NLP-31, FLP-9, FLP-21, FLP-24, NLP-
15, NLP-27, FLP-22 
(negative) regulation 
of metalloenzyme 
activity, (negative) 
regulation of 
membrane protein 
ectodomain 
proteolysis* 
2.73E-04 2 of 41 2 of 54514 CRI-2, K07C11.3 
single-multicellular 
organism process* 3.79E-04 16 of 41 
5401 of 
54514 
FLP-24, F20A1.1, NAS-36, GRD-10, 
FLP-12, BEST-24, LET-522, CAL-2, 
SNET-1, TNC-2, RPS-20, Y73F4A.2, 
STA-2, T26C5.4, PTR-8, F40F12.7 
(defense) response 
to fungus * 9.53E-04 3 of 41 
32 of 
54514 NLP-31, CNC-6, STA-2 
multi-organism 
process  1.51E-02 7 of 41 
1212 of 
54514 
NLP-31, FLP-21, F20A1.1, FLP-12, 
CNC-6, STA-2, C18E3.5 
biological regulation  1.96E-02 23 of 41 14131 of 54514 
NLP-31, FLP-9, FLP-21, FLP-24, 
W01B11.6, NLP-15, NLP-27, GRD-
10, FLP-12, BEST-24, TTR-48, CRI-2, 
LET-522, H05L03.3, TTR-32, SNET-
1, K07C11.3, RPS-20, STA-2, PTR-8, 
FLP-22, RIC-4, F40F12.7 
locomotion  3.28E-02 8 of 41 1873 of 54514 
NAS-36, NLP-15, GRD-10, BEST-24, 
LET-522, TTR-32, SNET-1, Y4C6B.2 
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